A	O
prominent	O
role	O
for	O
activator	B-protein
protein-1	I-protein
in	O
the	O
transcription	O
of	O
the	O
human	B-DNA
2B4	I-DNA
(	I-DNA
CD244	I-DNA
)	I-DNA
gene	I-DNA
in	O
NK	B-cell_type
cells	I-cell_type
.	O

The	O
cell	B-protein
surface	I-protein
glycoprotein	I-protein
2B4	I-protein
(	O
CD244	B-protein
)	O
of	O
the	O
Ig	B-protein
superfamily	I-protein
is	O
involved	O
in	O
the	O
regulation	O
of	O
NK	B-cell_type
and	O
T	B-cell_type
lymphocyte	I-cell_type
functions	O
.	O

We	O
have	O
recently	O
identified	O
CD48	B-protein
as	O
the	O
high	B-protein
affinity	I-protein
counterreceptor	I-protein
for	O
2B4	B-protein
in	O
both	O
mice	O
and	O
humans	O
.	O

The	O
cytoplasmic	B-protein
domain	I-protein
of	O
2B4	B-protein
associates	O
with	O
src	B-protein
homology	I-protein
2	I-protein
domain-containing	I-protein
protein	I-protein
or	O
signaling	B-protein
lymphocyte	I-protein
activation	I-protein
molecule-associated	I-protein
protein	I-protein
,	O
whose	O
mutation	O
is	O
the	O
underlying	O
genetic	O
defect	O
in	O
the	O
X-linked	O
lymphoproliferative	O
syndrome	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
the	O
molecular	O
cloning	O
and	O
characterization	O
of	O
the	O
human	B-DNA
2B4	I-DNA
(	I-DNA
h2B4	I-DNA
)	I-DNA
promoter	I-DNA
.	O

Through	O
primer	O
extension	O
analysis	O
,	O
we	O
found	O
that	O
the	O
transcription	O
of	O
the	O
h2B4	B-DNA
gene	I-DNA
initiates	O
at	O
multiple	O
start	O
sites	O
.	O

We	O
isolated	O
h2B4	B-DNA
genomic	I-DNA
clones	I-DNA
and	O
PCR	O
amplified	O
the	O
5	B-DNA
'	I-DNA
untranslated	I-DNA
region	I-DNA
containing	O
the	O
promoter	B-DNA
elements	I-DNA
.	O

We	O
have	O
identified	O
a	O
functional	O
AP-1	B-DNA
site	I-DNA
that	O
lies	O
between	O
(	O
-106	O
to	O
-100	O
)	O
through	O
transient	O
transfection	O
analysis	O
in	O
YT	B-cell_line
cells	I-cell_line
,	O
a	O
human	B-cell_line
NK	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

EMSAs	O
with	O
Abs	B-protein
specific	O
for	O
various	O
protein	B-protein
factors	I-protein
of	O
the	O
AP-1	B-protein
family	I-protein
revealed	O
that	O
multiple	O
members	O
of	O
the	O
Jun	B-protein
family	I-protein
are	O
involved	O
in	O
the	O
regulation	O
of	O
the	O
h2B4	B-DNA
gene	I-DNA
.	O

Mutation	O
of	O
the	O
AP-1	B-DNA
site	I-DNA
not	O
only	O
abolishes	O
protein/DNA	O
interactions	O
but	O
also	O
promoter	O
activity	O
.	O

These	O
results	O
demonstrate	O
a	O
significant	O
role	O
for	O
AP-1	B-protein
in	O
the	O
transcriptional	O
regulation	O
of	O
the	O
h2B4	B-DNA
gene	I-DNA
.	O

``	NULL
Th	NULL
VIVO	NULL
v	NULL
RE	NULL
SEAR	NULL
GCH	NULL
£	NULL
{	NULL
Discover	NULL
More	NULL
Me	NULL
BULK	NULL
ANTIBODIES	NULL
sam-	NULL
s	NULL
Ln	NULL
mJournal	NULL
f	NULL
A	NULL
Prominent	NULL
Role	NULL
for	NULL
Activator	NULL
Protein-1	NULL
in	NULL
Aﬁlmmunolo	NULL
gy	NULL
the	NULL
Transcription	NULL
of	NULL
the	NULL
Human	NULL
2B4	NULL
(	NULL
CD244	NULL
)	NULL
Gene	NULL
in	NULL
NK	NULL
Cells	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
_	NULL
Samuel	NULL
S.	NULL
Chuang	NULL
,	NULL
Hoang-Tuan	NULL
K.	NULL
Pham	NULL
,	NULL
Pappanaicken	NULL
R.	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Kumaresan	NULL
and	NULL
Porunelloor	NULL
A.	NULL
Mathew	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
166:6188-6195	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.166.10.6188	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/10/6188	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
59	NULL
articles	NULL
,	NULL
26	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/10/6188.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
A	NULL
Prominent	NULL
Role	NULL
for	NULL
Activator	NULL
Protein-1	NULL
in	NULL
the	NULL
Transcription	NULL
of	NULL
the	NULL
Human	NULL
2B4	NULL
(	NULL
CD244	NULL
)	NULL
Gene	NULL
in	NULL
NK	NULL
Cells	NULL
!	NULL

Samuel	NULL
S.	NULL
Chuang	NULL
,	NULL
Hoang-Tuan	NULL
K.	NULL
Pham	NULL
,	NULL
Pappanaicken	NULL
R.	NULL
Kumaresan	NULL
,	NULL
and	NULL
Porunelloor	NULL
A.	NULL
Mathew	NULL
The	NULL
cell	NULL
surface	NULL
glycoprotein	NULL
2B4	NULL
(	NULL
CD244	NULL
)	NULL
of	NULL
the	NULL
Ig	NULL
superfamily	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NK	NULL
and	NULL
T	NULL
lymphocyte	NULL
functions	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
identified	NULL
CD48	NULL
as	NULL
the	NULL
high	NULL
affinity	NULL
counterreceptor	NULL
for	NULL
2B4	NULL
in	NULL
both	NULL
mice	NULL
and	NULL
humans	NULL
.	NULL

The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
2B4	NULL
associates	NULL
with	NULL
sre	NULL
homology	NULL
2	NULL
domain-containing	NULL
protein	NULL
or	NULL
signaling	NULL
lymphocyte	NULL
activation	NULL
molecule-associated	NULL
protein	NULL
,	NULL
whose	NULL
mutation	NULL
is	NULL
the	NULL
underlying	NULL
genetic	NULL
defect	NULL
in	NULL
the	NULL
X-linked	NULL
lymphoproliferative	NULL
syndrome	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
report	NULL
the	NULL
molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
2B4	NULL
(	NULL
h2B4	NULL
)	NULL
promoter	NULL
.	NULL

Through	NULL
primer	NULL
extension	NULL
analysis	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
£2B4	NULL
gene	NULL
initiates	NULL
at	NULL
multiple	NULL
start	NULL
sites	NULL
.	NULL

We	NULL
isolated	NULL
h2B4	NULL
genomic	NULL
clones	NULL
and	NULL
PCR	NULL
amplified	NULL
the	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
containing	NULL
the	NULL
promoter	NULL
elements	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
functional	NULL
AP-1	NULL
site	NULL
that	NULL
lies	NULL
between	NULL
(	NULL
-106	NULL
to	NULL
-100	NULL
)	NULL
through	NULL
transient	NULL
transfection	NULL
analysis	NULL
in	NULL
YT	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
NK	NULL
cell	NULL
line	NULL
.	NULL

EMSAs	NULL
with	NULL
Abs	NULL
specific	NULL
for	NULL
various	NULL
protein	NULL
factors	NULL
of	NULL
the	NULL
AP-1	NULL
family	NULL
revealed	NULL
that	NULL
multiple	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
family	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
£2B4	NULL
gene	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
not	NULL
only	NULL
abolishes	NULL
protein/DNA	NULL
interactions	NULL
but	NULL
also	NULL
promoter	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
a	NULL
significant	NULL
role	NULL
for	NULL
AP-1	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
£2B4	NULL
gene	NULL
.	NULL

activation	NULL
of	NULL
NK	NULL
cell-mediated	NULL
cytotoxicity	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

2B4	NULL
was	NULL
originally	NULL
identified	NULL
on	NULL
mouse	NULL
NK	NULL
cells	NULL
and	NULL
the	NULL
subset	NULL
of	NULL
T	NULL
cells	NULL
that	NULL
mediate	NULL
non-MHC-restricted	NULL
killing	NULL
(	NULL
4-7	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
modulating	NULL
non-MHC-restricted	NULL
killing	NULL
,	NULL
2B4	NULL
activation	NULL
of	NULL
NK	NULL
cells	NULL
induces	NULL
cytokine	NULL
production	NULL
as	NULL
well	NULL
as	NULL
invasiveness	NULL
(	NULL
4	NULL
,	NULL
8	NULL
)	NULL
.	NULL

It	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ig	NULL
superfamily	NULL
and	NULL
belongs	NULL
to	NULL
the	NULL
CD2	NULL
subset	NULL
that	NULL
includes	NULL
signaling	NULL
lymphocyte-activation	NULL
molecule	NULL
(	NULL
SLAM	NULL
)	NULL
,	NULL
CD48	NULL
,	NULL
CD58	NULL
,	NULL
CD84	NULL
,	NULL
and	NULL
Ly9	NULL
.	NULL

Human	NULL
2B4	NULL
(	NULL
h2B4	NULL
)	NULL
``	NULL
is	NULL
found	NULL
on	NULL
all	NULL
NK	NULL
cells	NULL
,	NULL
a	NULL
subset	NULL
of	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
basophils	NULL
(	NULL
2	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
identified	NULL
CD48	NULL
as	NULL
the	NULL
high	NULL
affinity	NULL
counterreceptor	NULL
of	NULL
2B4	NULL
in	NULL
both	NULL
mice	NULL
and	NULL
humans	NULL
(	NULL
9	NULL
)	NULL
.	NULL

CD48-2B4	NULL
interactions	NULL
are	NULL
physiologically	NULL
important	NULL
because	NULL
they	NULL
enhance	NULL
the	NULL
lytic	NULL
function	NULL
of	NULL
human	NULL
NK	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
2B4	NULL
may	NULL
function	NULL
as	NULL
a	NULL
coreceptor	NULL
in	NULL
human	NULL
NK	NULL
cell	NULL
activation	NULL
(	NULL
10	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
found	NULL
that	NULL
2B4	NULL
associates	NULL
with	NULL
the	NULL
signaling	NULL
adapter	NULL
molecule	NULL
SLAM-associated	NULL
protein	NULL
(	NULL
SAP	NULL
)	NULL
/Sre	NULL
homology	NULL
2	NULL
domain-containing	NULL
protein	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
Src	NULL
homology	NULL
2	NULL
domain	NULL
of	NULL
SAP/Src	NULL
homology	NULL
2	NULL
domain-containing	NULL
protein	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
genetic	NULL
defect	NULL
in	NULL
X-linked	NULL
lymphoproliferative	NULL
disease	NULL
(	NULL
XLPD	NULL
)	NULL
,	NULL
and	NULL
a	NULL
number	NULL
of	NULL
recent	NULL
studies	NULL
demonstrated	NULL
that	NULL
2B4	NULL
signaling	NULL
is	NULL
defective	NULL
in	NULL
XLPD	NULL
(	NULL
12-17	NULL
)	NULL
.	NULL

Another	NULL
study	NULL
of	NULL
XLPD	NULL
patients	NULL
showed	NULL
that	NULL
not	NULL
only	NULL
does	NULL
2B4	NULL
T	NULL
he	NULL
surface	NULL
molecule	NULL
2B4	NULL
(	NULL
CD244	NULL
)	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
and	NULL
Immunology	NULL
and	NULL
Institute	NULL
for	NULL
Cancer	NULL
Re-search	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Texas	NULL
Health	NULL
Science	NULL
Center	NULL
at	NULL
Fort	NULL
Worth	NULL
,	NULL
Fort	NULL
Worth	NULL
,	NULL
TX	NULL
76107	NULL
Received	NULL
for	NULL
publication	NULL
September	NULL
1	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
14	NULL
,	NULL
2001	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
AI	NULL
38938.	NULL
?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Porunelloor	NULL
Mathew	NULL
,	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
North	NULL
Texas	NULL
Health	NULL
Science	NULL
Center	NULL
at	NULL
Fort	NULL
Worth	NULL
,	NULL
3500	NULL
Camp	NULL
Bowie	NULL
Boulevard	NULL
,	NULL
Fort	NULL
Worth	NULL
,	NULL
TX	NULL
76107-2699	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
pmathew	NULL
@	NULL
hsc.unt.edu	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
h2B4	NULL
,	NULL
human	NULL
2B4	NULL
;	NULL
SLAM	NULL
,	NULL
signaling	NULL
lymphocyte-activation	NULL
molecule	NULL
;	NULL
SAP	NULL
,	NULL
SLAM-associated	NULL
protein	NULL
;	NULL
XLPD	NULL
,	NULL
X-linked	NULL
lymphoprolif-crative	NULL
disease	NULL
;	NULL
m2B4	NULL
,	NULL
mouse	NULL
2B4	NULL
;	NULL
MAP	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
.	NULL

Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
166	NULL
:	NULL
6188-6195.	NULL
fail	NULL
to	NULL
transduce	NULL
activating	NULL
signals	NULL
in	NULL
NK	NULL
cells	NULL
but	NULL
that	NULL
CD48-2B4	NULL
interactions	NULL
inhibited	NULL
activating	NULL
signals	NULL
transduced	NULL
by	NULL
other	NULL
stimulatory	NULL
molecules	NULL
including	NULL
CD16	NULL
,	NULL
NKp46	NULL
,	NULL
NKp44	NULL
,	NULL
and	NULL
NKp30	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
by	NULL
Peritt	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
2B4	NULL
on	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
is	NULL
a	NULL
better	NULL
predictor	NULL
of	NULL
disease	NULL
progression	NULL
in	NULL
AIDS	NULL
patients	NULL
than	NULL
CD4	NULL
*	NULL
T	NULL
cell	NULL
levels	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Although	NULL
no	NULL
polymorphism	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
humans	NULL
,	NULL
our	NULL
studies	NULL
of	NULL
2B4	NULL
in	NULL
inbred	NULL
mouse	NULL
strains	NULL
demonstrate	NULL
polymorphism	NULL
in	NULL
the	NULL
extracellular	NULL
domain	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Over	NULL
the	NULL
last	NULL
few	NULL
years	NULL
,	NULL
a	NULL
wealth	NULL
of	NULL
information	NULL
has	NULL
been	NULL
accumulated	NULL
on	NULL
the	NULL
identification	NULL
,	NULL
ligand	NULL
interactions	NULL
,	NULL
and	NULL
signaling	NULL
pathways	NULL
of	NULL
several	NULL
receptors	NULL
expressed	NULL
on	NULL
NK	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
knowledge	NULL
of	NULL
the	NULL
mechanisms	NULL
underlying	NULL
the	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
receptors	NULL
is	NULL
fragmentary	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
transcriptional	NULL
regulation	NULL
as	NULL
well	NULL
as	NULL
the	NULL
mechanisms	NULL
controlling	NULL
the	NULL
restricted	NULL
expression	NULL
of	NULL
the	NULL
2B4	NULL
gene	NULL
,	NULL
we	NULL
conducted	NULL
preliminary	NULL
analysis	NULL
in	NULL
characterizing	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
mouse	NULL
2B4	NULL
(	NULL
m2B4	NULL
)	NULL
gene	NULL
.	NULL

Our	NULL
studies	NULL
demonstrated	NULL
that	NULL
transcription	NULL
of	NULL
m2B4	NULL
did	NULL
not	NULL
start	NULL
at	NULL
a	NULL
conserved	NULL
initiation	NULL
site	NULL
and	NULL
was	NULL
driven	NULL
by	NULL
a	NULL
TATA-less	NULL
promoter	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
transient	NULL
transfections	NULL
with	NULL
fragments	NULL
of	NULL
the	NULL
2B4	NULL
promoter	NULL
revealed	NULL
cell-specific	NULL
promoter	NULL
activity	NULL
in	NULL
cells	NULL
that	NULL
express	NULL
2B4	NULL
only	NULL
(	NULL
21	NULL
)	NULL
.	NULL

This	NULL
study	NULL
was	NULL
performed	NULL
to	NULL
understand	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
A2B4	NULL
gene	NULL
.	NULL

To	NULL
accomplish	NULL
this	NULL
,	NULL
we	NULL
isolated	NULL
a	NULL
genomic	NULL
clone	NULL
of	NULL
h2B4	NULL
from	NULL
a	NULL
A	NULL
phage	NULL
library	NULL
and	NULL
identified	NULL
>	NULL
1	NULL
kb	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
of	NULL
the	NULL
h2B4	NULL
gene	NULL
.	NULL

We	NULL
undertook	NULL
the	NULL
task	NULL
of	NULL
characterizing	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
h2B4	NULL
gene	NULL
by	NULL
constructing	NULL
5	NULL
'	NULL
nested	NULL
deletion	NULL
constructs	NULL
and	NULL
assayed	NULL
their	NULL
promoter	NULL
activity	NULL
by	NULL
transient	NULL
transfection	NULL
of	NULL
YT	NULL
cells	NULL
,	NULL
a	NULL
NK	NULL
tumor	NULL
cell	NULL
line	NULL
.	NULL

We	NULL
present	NULL
evidence	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
AP-1	NULL
site	NULL
located	NULL
at	NULL
-106	NULL
to	NULL
-100	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
strongly	NULL
activates	NULL
transcription	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
culture	NULL
and	NULL
reagents	NULL
YT	NULL
(	NULL
human	NULL
NK	NULL
tumor	NULL
cell	NULL
line	NULL
)	NULL
and	NULL
K562	NULL
(	NULL
human	NULL
tumor	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
4	NULL
+	NULL
RPMI	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
sup	NULL
plemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
nonessential	NULL
amino	NULL
acids	NULL
)	NULL
.	NULL

NK-92	NULL
(	NULL
human	NULL
NK	NULL
tumor	NULL
cell	NULL
line	NULL
)	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
«	NULL
complete	NULL
medium	NULL
(	NULL
«	NULL
MEM	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
1.5	NULL
g/L	NULL
sodium	NULL
bicarbonate	NULL
,	NULL
0.2	NULL
mM	NULL
inositol	NULL
,	NULL
0.1	NULL
mM	NULL
2-ME	NULL
,	NULL
0.02	NULL
mM	NULL
folic	NULL
acid	NULL
,	NULL
200	NULL
U/ml	NULL
rIL-2	NULL
,	NULL
12.5	NULL
%	NULL
horse	NULL
serum	NULL
,	NULL
and	NULL
12.5	NULL
%	NULL
FBS	NULL
)	NULL
.	NULL

Growth	NULL
was	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
/95	NULL
%	NULL
air	NULL
incubator	NULL
.	NULL

Cell	NULL
culture	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Life	NULL
Technologies	NULL
(	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
unless	NULL
otherwise	NULL
noted	NULL
.	NULL

C1.7	NULL
Ab	NULL
,	NULL
which	NULL
recognizes	NULL
h2B4	NULL
(	NULL
11	NULL
)	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
Coulter	NULL
(	NULL
Orlando	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Affinity-purified	NULL
rabbit	NULL
anti-mouse	NULL
Abs	NULL
against	NULL
c-Jun	NULL
(	NULL
catalog	NULL
no	NULL
.	NULL

SC-822X	NULL
)	NULL
,	NULL
c-Fos	NULL
(	NULL
catalog	NULL
no	NULL
.	NULL

SC-253X	NULL
)	NULL
,	NULL
and	NULL
JunB	NULL
(	NULL
catalog	NULL
no	NULL
.	NULL

SC-8051X	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

All	NULL
enzymes	NULL
were	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
unless	NULL
otherwise	NULL
stated	NULL
.	NULL

pGL2	NULL
and	NULL
pRL	NULL
vectors	NULL
and	NULL
dual-luciferase	NULL
reporter	NULL
assay	NULL
system	NULL
were	NULL
purchased	NULL
from	NULL
Promega	NULL
(	NULL
Mad-ison	NULL
,	NULL
WD	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
dL	NULL
:	NULL
dC	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
(	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

All	NULL
custom	NULL
synthesized	NULL
oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
supplied	NULL
by	NULL
Integrated	NULL
DNA	NULL
Technologies	NULL
(	NULL
Coralville	NULL
,	NULL
IA	NULL
)	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
and	NULL
plasmid	NULL
construction	NULL
A	NULL
human	NULL
genomic	NULL
DNA	NULL
library	NULL
constructed	NULL
in	NULL
Fix	NULL
II	NULL
phagemid	NULL
vector	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
screened	NULL
with	NULL
full-length	NULL
[	NULL
a-*P	NULL
]	NULL
dCTP-labeled	NULL
h2B4	NULL
cDNA	NULL
as	NULL
probe	NULL
.	NULL

Full-length	NULL
labeled	NULL
h2B4	NULL
cDNA	NULL
probe	NULL
was	NULL
generated	NULL
using	NULL
[	NULL
a-*P	NULL
]	NULL
dCTP	NULL
(	NULL
DuPont-NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
the	NULL
Mega-prime	NULL
kit	NULL
from	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
.	NULL

Using	NULL
Escherichia	NULL
coli	NULL
XL1-blue	NULL
as	NULL
host	NULL
strain	NULL
,	NULL
1	NULL
X	NULL
10°	NULL
plaques	NULL
were	NULL
plated	NULL
and	NULL
lifted	NULL
onto	NULL
nylon	NULL
N	NULL
(	NULL
+	NULL
)	NULL
Hybond	NULL
membrane	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
according	NULL
to	NULL
standard	NULL
protocols	NULL
.	NULL

After	NULL
three	NULL
successive	NULL
rounds	NULL
of	NULL
screening	NULL
,	NULL
nine	NULL
different	NULL
positive	NULL
phage	NULL
clones	NULL
were	NULL
isolated	NULL
and	NULL
phage	NULL
DNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
)	NULL
.	NULL

Partial	NULL
sequencing	NULL
of	NULL
the	NULL
genomic	NULL
clones	NULL
was	NULL
performed	NULL
by	NULL
automated	NULL
sequencing	NULL
(	NULL
sequencing	NULL
facility	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
)	NULL
using	NULL
specific	NULL
oligonucleotides	NULL
based	NULL
on	NULL
h2B4	NULL
cDNA	NULL
A19A1A	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Nested	NULL
promoter	NULL
fragments	NULL
were	NULL
derived	NULL
by	NULL
PCR	NULL
using	NULL
Tag	NULL
polymerase	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
using	NULL
genomic	NULL
DNA	NULL
clone	NULL
(	NULL
F5A1	NULL
)	NULL
containing	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
of	NULL
the	NULL
h2B4	NULL
gene	NULL
as	NULL
template	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Various	NULL
5°	NULL
20-22	NULL
base	NULL
primers	NULL
were	NULL
designed	NULL
to	NULL
incorporate	NULL
a	NULL
KpnI	NULL
site	NULL
for	NULL
ease	NULL
of	NULL
subcloning	NULL
.	NULL

The	NULL
3	NULL
'	NULL
primer	NULL
,	NULL
identical	NULL
for	NULL
all	NULL
the	NULL
constructs	NULL
,	NULL
was	NULL
designed	NULL
with	NULL
a	NULL
Xho	NULL
!	NULL

site	NULL
and	NULL
ended	NULL
at	NULL
nucleotide	NULL
+126	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
nested	NULL
promoter	NULL
fragments	NULL
were	NULL
then	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
promot-erless	NULL
and	NULL
enhancerless	NULL
firefly	NULL
luciferase	NULL
gene	NULL
in	NULL
the	NULL
pGL	NULL
,	NULL
-B	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
numbering	NULL
of	NULL
the	NULL
constructs	NULL
refers	NULL
to	NULL
the	NULL
first	NULL
nucleotide	NULL
of	NULL
each	NULL
promoter	NULL
construct	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
PCR-derived	NULL
fragments	NULL
were	NULL
digested	NULL
with	NULL
KpnI	NULL
and	NULL
Xho	NULL
!	NULL

and	NULL
ligated	NULL
into	NULL
similarly	NULL
digested	NULL
pGL	NULL
,	NULL
-B	NULL
vector	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
nucleotide	NULL
sequencing	NULL
.	NULL

Substitution	NULL
mutant	NULL
promoter	NULL
constructs	NULL
were	NULL
generated	NULL
by	NULL
a	NULL
two-step	NULL
PCR	NULL
procedure	NULL
using	NULL
overlapping	NULL
internal	NULL
primers	NULL
that	NULL
contain	NULL
a	NULL
mutant	NULL
sequence	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

A	NULL
Renilla	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
pRL-CMV	NULL
driven	NULL
by	NULL
an	NULL
upstream	NULL
CMV	NULL
immediate-early	NULL
enhancer/promoter	NULL
region	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
pGL	NULL
,	NULL
promoter	NULL
constructs	NULL
to	NULL
adjust	NULL
firefly	NULL
luciferase	NULL
activity	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

All	NULL
plasmid	NULL
DNA	NULL
used	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
were	NULL
purified	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
CsCI1	NULL
centrifugation	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
Primer	NULL
extension	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
modified	NULL
procedure	NULL
as	NULL
described	NULL
by	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
primer	NULL
used	NULL
for	NULL
primer	NULL
extension	NULL
analysis	NULL
codes	NULL
for	NULL
the	NULL
complementary	NULL
sequence	NULL
to	NULL
the	NULL
region	NULL
(	NULL
+127	NULL
to	NULL
+107	NULL
)	NULL
from	NULL
relative	NULL
to	NULL
the	NULL
first	NULL
base	NULL
of	NULL
the	NULL
h2B4	NULL
start	NULL
of	NULL
transcription	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Table	NULL
I	NULL
.	NULL

-	NULL
Oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
6189	NULL
The	NULL
primer	NULL
was	NULL
end-labeled	NULL
with	NULL
[	NULL
y-*P	NULL
]	NULL
dATP	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
6000	NULL
Ci/	NULL
mmol	NULL
)	NULL
(	NULL
DuPont-NEN	NULL
)	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
New	NULL
England	NULL
Bio-labs	NULL
)	NULL
.	NULL

Six	NULL
micrograms	NULL
total	NULL
RNA	NULL
from	NULL
YT	NULL
cells	NULL
was	NULL
heated	NULL
to	NULL
70°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
iced	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Labeled	NULL
primer	NULL
(	NULL
200	NULL
fmol	NULL
)	NULL
was	NULL
annealed	NULL
to	NULL
YT	NULL
total	NULL
RNA	NULL
at	NULL
85°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
then	NULL
cooled	NULL
to	NULL
42°C	NULL
.	NULL

Primer	NULL
extension	NULL
assays	NULL
were	NULL
conducted	NULL
using	NULL
Superscript	NULL
II	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
at	NULL
42°C	NULL
for	NULL
2	NULL
h	NULL
and	NULL
resolved	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
sequencing	NULL
gel	NULL
.	NULL

A	NULL
G+A	NULL
sequencing	NULL
reaction	NULL
was	NULL
conducted	NULL
and	NULL
run	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
samples	NULL
during	NULL
electrophoresis	NULL
as	NULL
a	NULL
marker	NULL
.	NULL

The	NULL
G+	NULL
A	NULL
ladder	NULL
was	NULL
generated	NULL
using	NULL
a	NULL
Maxam-Gilbert	NULL
sequencing	NULL
reaction	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Transfection	NULL
and	NULL
luciferase	NULL
assays	NULL
YT	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
each	NULL
of	NULL
the	NULL
4	NULL
ug	NULL
of	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
,	NULL
and	NULL
400	NULL
ng	NULL
of	NULL
pRL-CMV	NULL
,	NULL
a	NULL
Renilla	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
for	NULL
internal	NULL
normalization	NULL
of	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
DMRIE-C	NULL
reagent	NULL
at	NULL
a	NULL
2.2:3	NULL
ratio	NULL
of	NULL
ug	NULL
DNA/ul	NULL
DMRIE-C	NULL
reagent	NULL
as	NULL
per	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
harvested	NULL
40	NULL
h	NULL
poststimulation	NULL
.	NULL

Firefly	NULL
and	NULL
Renilla	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
Dual-Luciferase	NULL
reporter	NULL
assay	NULL
system	NULL
as	NULL
per	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Each	NULL
test	NULL
promoter	NULL
construct	NULL
was	NULL
cotransfected	NULL
with	NULL
pRL-CMV	NULL
into	NULL
YT	NULL
cells	NULL
in	NULL
at	NULL
least	NULL
four	NULL
independent	NULL
trials	NULL
.	NULL

Human	NULL
NK	NULL
cell	NULL
isolation	NULL
Peripheral	NULL
blood	NULL
from	NULL
healthy	NULL
donors	NULL
was	NULL
diluted	NULL
with	NULL
two	NULL
volumes	NULL
of	NULL
PBS	NULL
and	NULL
then	NULL
layered	NULL
over	NULL
Ficoll	NULL
Pague	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

It	NULL
was	NULL
then	NULL
subjected	NULL
to	NULL
centrifugation	NULL
at	NULL
400	NULL
X	NULL
g	NULL
for	NULL
30	NULL
min	NULL
.	NULL

PBMC	NULL
were	NULL
then	NULL
extracted	NULL
from	NULL
the	NULL
interface	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
three	NULL
volumes	NULL
of	NULL
HBSS	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
wash	NULL
with	NULL
one	NULL
volume	NULL
of	NULL
HBSS	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
then	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
PBS	NULL
(	NULL
containing	NULL
0.5	NULL
%	NULL
BSA	NULL
)	NULL
.	NULL

The	NULL
NK	NULL
cells	NULL
were	NULL
then	NULL
purified	NULL
using	NULL
an	NULL
NK	NULL
cell	NULL
isolation	NULL
kit	NULL
from	NULL
Miltenyi	NULL
Biotec	NULL
(	NULL
Auburn	NULL
,	NULL
CA	NULL
)	NULL
per	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Nuclear	NULL
extraction	NULL
and	NULL
EMSA	NULL
Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
YT	NULL
cells	NULL
,	NULL
NK-92	NULL
cells	NULL
,	NULL
and	NULL
freshly	NULL
isolated	NULL
human	NULL
NK	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
protein-DNA	NULL
binding	NULL
reactions	NULL
were	NULL
conducted	NULL
(	NULL
29	NULL
)	NULL
.	NULL

A	NULL
typical	NULL
binding	NULL
reaction	NULL
mixture	NULL
contained	NULL
2	NULL
pug	NULL
of	NULL
nuclear	NULL
protein	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI	NULL
:	NULL
dC	NULL
)	NULL
,	NULL
and	NULL
radiolabeled	NULL
oligonucleotide	NULL
(	NULL
20,000	NULL
cpm	NULL
,	NULL
~0.2	NULL
ng	NULL
)	NULL
in	NULL
10	NULL
pl	NULL
reaction	NULL
volume	NULL
.	NULL

All	NULL
double-stranded	NULL
oligonucleotide	NULL
sequences	NULL
are	NULL
listed	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
electrophoresed	NULL
through	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
nondenaturing	NULL
condition	NULL
in	NULL
0.25	NULL
%	NULL
Tris-borate-EDTA	NULL
at	NULL
200	NULL
V	NULL
for	NULL
70	NULL
min	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
film	NULL
.	NULL

The	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

For	NULL
competition	NULL
analysis	NULL
,	NULL
100	NULL
and	NULL
200	NULL
molar	NULL
excess	NULL
amounts	NULL
of	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

Results	NULL
Isolation	NULL
of	NULL
5	NULL
``	NULL
flanking	NULL
sequences	NULL
of	NULL
the	NULL
h2B4	NULL
gene	NULL
To	NULL
obtain	NULL
h2B4	NULL
genomic	NULL
clones	NULL
and	NULL
to	NULL
isolate	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
,	NULL
we	NULL
screened	NULL
a	NULL
human	NULL
genomic	NULL
library	NULL
constructed	NULL
in	NULL
FIX	NULL
II	NULL
phagemid	NULL
vector	NULL
(	NULL
Stratagene	NULL
)	NULL
using	NULL
full-length	NULL
h2B4	NULL
cDNA	NULL
as	NULL
probe	NULL
.	NULL

Nine	NULL
genomic	NULL
clones	NULL
were	NULL
isolated	NULL
and	NULL
EcoRI	NULL
endonuclease	NULL
digestion	NULL
was	NULL
conducted	NULL
on	NULL
each	NULL
clone	NULL
.	NULL

Name	NULL
Gene	NULL
Sequence*	NULL
``	NULL
Position®	NULL
F5SA1-FP	NULL
h2B4	NULL
5'-AAGACAGGGTGGCTTGC-3	NULL
'	NULL
-1151	NULL
to	NULL
-1135	NULL
F5SAI-RP	NULL
h2B4	NULL
5-CACAGCTCCTAGTCCCTC-3	NULL
'	NULL
+285	NULL
to	NULL
+268	NULL
+hpro-DBS1	NULL
h2B4	NULL
5-CTTTGTGAGTCACTGTGAACTTC-3	NULL
'	NULL
-111	NULL
to	NULL
-89	NULL
-hpro-DBS1	NULL
h2B4	NULL
3'-GAAACACTCAGTGACACTTGAAG-5	NULL
'	NULL
-89	NULL
to	NULL
-111	NULL
+AP-1	NULL
5-CGCTTGATGAGTCAGCCGGAA-3	NULL
``	NULL
-AP-1	NULL
3'-GCGAACTACTCAGTCGGCCTT-5	NULL
'	NULL
+NF-	NULL
«	NULL
B	NULL
5-CGAGGTGAAAATCCCTCAGCT-3	NULL
'	NULL
-NF-	NULL
«	NULL
B	NULL
5-GCTCCACTTTTAGGGAGTCGA-3	NULL
'	NULL
+DBS1-M	NULL
h2B4	NULL
5'-CTTTGTeegTCACTGTGAACTTC-3	NULL
'	NULL
-111	NULL
to	NULL
-89	NULL
-DBS1-M	NULL
h2B4	NULL
5-GAAGTTCACAGTGAcggACAAAG-3	NULL
'	NULL
-89	NULL
to	NULL
-111	NULL
``	NULL
Complementary	NULL
strands	NULL
were	NULL
annealed	NULL
as	NULL
shown	NULL
.	NULL

*	NULL
Lower	NULL
case	NULL
lettering	NULL
denote	NULL
those	NULL
bases	NULL
mutated	NULL
.	NULL

©	NULL
The	NULL
nucleotide	NULL
positions	NULL
are	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
site	NULL
of	NULL
each	NULL
respective	NULL
gene	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6190	NULL
TRANSCRIPTIONAL	NULL
REGULATION	NULL
OF	NULL
THE	NULL
HUMAN	NULL
2B4	NULL
(	NULL
CD244	NULL
)	NULL
GENE	NULL
Four	NULL
different	NULL
genomic	NULL
clones	NULL
with	NULL
insert	NULL
sizes	NULL
ranging	NULL
from	NULL
20	NULL
to	NULL
30	NULL
kb	NULL
were	NULL
chosen	NULL
for	NULL
further	NULL
study	NULL
.	NULL

One	NULL
of	NULL
the	NULL
genomic	NULL
clones	NULL
,	NULL
F5A1	NULL
,	NULL
contained	NULL
a	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
relative	NULL
to	NULL
the	NULL
h2B4	NULL
gene	NULL
.	NULL

Approximately	NULL
1500	NULL
bases	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
(	NULL
GenBank	NULL
accession	NULL
no	NULL
.	NULL

AF297616	NULL
)	NULL
5	NULL
``	NULL
to	NULL
the	NULL
h2B4	NULL
gene	NULL
was	NULL
amplified	NULL
by	NULL
using	NULL
forward	NULL
primer	NULL
F5A1-FP	NULL
and	NULL
reverse	NULL
primer	NULL
F5A1-RP	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
the	NULL
genomic	NULL
structure	NULL
of	NULL
h2B4	NULL
has	NULL
already	NULL
been	NULL
reported	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
h2B4	NULL
gene	NULL
is	NULL
initiated	NULL
at	NULL
multiple	NULL
start	NULL
sites	NULL
To	NULL
identify	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
we	NULL
performed	NULL
primer	NULL
extension	NULL
using	NULL
total	NULL
RNA	NULL
extracted	NULL
from	NULL
YT	NULL
and	NULL
NK92	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
YT	NULL
cells	NULL
express	NULL
h2B4	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
found	NULL
through	NULL
FACS	NULL
analysis	NULL
with	NULL
C1.7	NULL
mAb	NULL
(	NULL
a-h2B4	NULL
)	NULL
conjugated	NULL
with	NULL
FITC	NULL
,	NULL
that	NULL
NK92	NULL
cells	NULL
also	NULL
express	NULL
h2B4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
using	NULL
total	NULL
RNA	NULL
from	NULL
YT	NULL
cells	NULL
revealed	NULL
several	NULL
extended	NULL
extension	NULL
products	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
m2B4	NULL
gene	NULL
,	NULL
the	NULL
h2B4	NULL
gene	NULL
does	NULL
not	NULL
have	NULL
a	NULL
conserved	NULL
initiation	NULL
start	NULL
site	NULL
nor	NULL
does	NULL
it	NULL
contain	NULL
a	NULL
TATA	NULL
box	NULL
near	NULL
the	NULL
transcription	NULL
initiation	NULL
start	NULL
sites	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
repeated	NULL
on	NULL
total	NULL
RNA	NULL
extracted	NULL
from	NULL
NK92	NULL
cells	NULL
produced	NULL
identical	NULL
extension	NULL
products	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
h2B4	NULL
promoter	NULL
activity	NULL
To	NULL
identify	NULL
the	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
that	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
h2B4	NULL
gene	NULL
,	NULL
we	NULL
performed	NULL
transient	NULL
-1151	NULL
-	NULL
AAGACAGGGT	NULL
GGCTTGGAAA	NULL
TGCACCAAAG	NULL
GATGGAAAAA	NULL
GAGAATAAGA	NULL
CCGGACTTGA	NULL
AGCGAACTGA	NULL
AAGTATTTGT	NULL
TAAGGGGAAA	NULL
GCAGAAGGAA	NULL
-1051	NULL
GAAAGAAAGA	NULL
GGCATGAACC	NULL
CTGGGGCCTG	NULL
GCCTTGAAGC	NULL
ACAGTGTTCC	NULL
AGGGGAGGGG	NULL
GGATGCCGCT	NULL
GTCCCCACCC	NULL
CPCCATGGGG	NULL
GCCTAAGCAG	NULL
-951	NULL
-	NULL
ATCCAGAGCT	NULL
GCCTGGCCPT	NULL
CCTGGAGGGT	NULL
GeceTccaat	NULL
CaTGeATGGe	NULL
AAGGCAGCAA	NULL
AAATAGGCCC	NULL
ATGTCACTTN	NULL
TGGGAGAAGA	NULL
CAAAAGAGGG	NULL
-851	NULL
-	NULL
AAGAGAGGCAC	NULL
TACTATAGAA	NULL
AAGTAGAAAA	NULL
AGAGGAAGGG	NULL
AGGGAATCTA	NULL
GGCATACAGA	NULL
TCGGAAATGT	NULL
GGAGCAAAAC	NULL
AAAATTTTTT	NULL
TPITTTTTTT	NULL
-751	NULL
-	NULL
TGAGACACAG	NULL
TGTCGCTCTG	NULL
TCACCTAGGC	NULL
TGGAGTGCAG	NULL
TGGCGTGATC	NULL
TPEGCTTACC	NULL
GCAACCTCCA	NULL
CCTCCPTTGC	NULL
TCAAGTGATT	NULL
CCCCTeCCTC	NULL
GeceacTecTt	NULL
GAGCCCGTGC	NULL
ACGGCAGAGA	NULL
GTCPeeTcee	NULL
GTecaccecc	NULL
-651	NULL
_	NULL
AGCCTCCCAA	NULL
GTAGCTTGGA	NULL
TPACAGGTGC	NULL
ACGCCACCCA	NULL
GCCTGGCTAA	NULL
TPTCTCTATT	NULL
TTTAGTAGAG	NULL
GTGGGGATTC	NULL
ACCATATTGG	NULL
CCAGGCTAGT	NULL
-551	NULL
-	NULL
CPCGATCTCC	NULL
TGATCTCAAG	NULL
TGATCTGCCT	NULL
GCTTCAGTCT	NULL
CCCAAAGTGT	NULL
TGGGATTACA	NULL
GCCGTGAGCC	NULL
ACTGTGCCCC	NULL
GTGTGAAACA	NULL
AATTCTTATG	NULL
-451	NULL
-	NULL
AAACAAATTT	NULL
AATTTACATG	NULL
TGCTTAAACT	NULL
TTGGTGTCAA	NULL
CTTGCATGGA	NULL
Oct-1/O0ct-2	NULL
ATCCCCAGGC	NULL
TTGCTAGATT	NULL
TTTCTAGTGC	NULL
CTCCAGCCCT	NULL
TAGGTCTCTT	NULL
Ap-2	NULL
-351	NULL
-	NULL
CCTATGTTCT	NULL
CPCAGCTACT	NULL
CCTCCTTTCC	NULL
TTCAACACTG	NULL
TTAGCCGCTT	NULL
ATCCAGGGCC	NULL
CTACGTTTCA	NULL
GCCCACTCCT	NULL
CCTCCAGCCC	NULL
CTCTCCcacre	NULL
-251	NULL
-	NULL
CACCTCCACA	NULL
ATGTCTGTTG	NULL
GAATGGAACA	NULL
GTTGGGeATA	NULL
CTGGCTeTTT	NULL
Ap-2	NULL
GATA	NULL
GGCCCCCATG	NULL
GGGGTCTCTC	NULL
CATATAGGAT	NULL
TCAGAGAATT	NULL
GGAAGACTTC	NULL
-151	NULL
-	NULL
TRGGGCTCAA	NULL
GCAGAGAACG	NULL
GGATGCAATT	NULL
TTGAAACTGG	NULL
CTTTGTGAGT	NULL
Ap-1	NULL
CACTGTGAAC	NULL
TPCAAGCACC_CTCCCACTTG	NULL
AGGTAAGCTT	NULL
CACCAGTTTG	NULL
C/EBP	NULL
-51	NULL
GCTTGTGGGA	NULL
ACTGTCAGAC	NULL
CAGCTCCAGG	NULL
CGCTGeegCT	NULL
TrCTCaGTGG	NULL
STAT-X	NULL
CGTTGTCAGC	NULL
TCACAGCAGG	NULL
CGTTAACAGC	NULL
CTCTAATTGA	NULL
GGAAACTGTG	NULL
+1	NULL
Start	NULL
of	NULL
Transcription	NULL
+50	NULL
-	NULL
GCTGGACAGG	NULL
TTGCAAGGCA	NULL
GTTCTGCTCC	NULL
CCATCGTCCP	NULL
CTTGCTGACT	NULL
*	NULL
cDNA	NULL
Start	NULL
ceccactecr	NULL
cacccceree	NULL
aceecacaca	NULL
ercreetece	NULL
Grecaceesc	NULL
+150	NULL
-	NULL
rescomesec	NULL
CCremeTcer	NULL
erecamaTec	NULL
GGrcaccere	NULL
ATACTCCTCC	NULL
TGCTCCTCAA	NULL
GGTGTATCAG	NULL
GECAAAGGTA	NULL
AGGAGGTCCT	NULL
+250	NULL
ccceceaccca	NULL
gecactacca	NULL
ccrere	NULL
FIGURE	NULL
1	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
5°	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
A2B4	NULL
gene	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
was	NULL
analyzed	NULL
and	NULL
screened	NULL
for	NULL
potential	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
using	NULL
TESS	NULL
:	NULL
transcription	NULL
element	NULL
search	NULL
site	NULL
(	NULL
hitp	NULL
:	NULL
/agave.humgen.upenn.edu/tess	NULL
)	NULL
.	NULL

Several	NULL
potential	NULL
transcription	NULL
fac-tor-binding	NULL
sites	NULL
are	NULL
underlined	NULL
.	NULL

*	NULL
,	NULL
First	NULL
base	NULL
of	NULL
the	NULL
h2B4	NULL
cDNA	NULL
clone	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
initiation	NULL
start	NULL
sites	NULL
revealed	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
.	NULL

The	NULL
numbers	NULL
on	NULL
the	NULL
left	NULL
indicate	NULL
the	NULL
nucleotide	NULL
positions	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
based	NULL
on	NULL
the	NULL
most	NULL
3	NULL
'	NULL
initiation	NULL
start	NULL
site	NULL
designated	NULL
as	NULL
+1	NULL
.	NULL

-108	NULL
-34	NULL
-26	NULL
~14	NULL
+1	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Primer	NULL
extension	NULL
analysis	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
identified	NULL
multiple	NULL
initiation	NULL
start	NULL
sites	NULL
.	NULL

An	NULL
h2B4	NULL
specific	NULL
primer	NULL
annealing	NULL
to	NULL
sequences	NULL
downstream	NULL
of	NULL
the	NULL
first	NULL
base	NULL
of	NULL
the	NULL
cDNA	NULL
clone	NULL
of	NULL
h2B4	NULL
was	NULL
annealed	NULL
to	NULL
6	NULL
ug	NULL
of	NULL
YT	NULL
total	NULL
RNA	NULL
.	NULL

The	NULL
primer	NULL
extension	NULL
assay	NULL
was	NULL
conducted	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
same	NULL
primer	NULL
was	NULL
used	NULL
with	NULL
an	NULL
upstream	NULL
primer	NULL
to	NULL
generate	NULL
the	NULL
G+A	NULL
ladder	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Arrows	NULL
and	NULL
numbers	NULL
indicate	NULL
the	NULL
primer	NULL
extension	NULL
products	NULL
resolved	NULL
and	NULL
their	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
most	NULL
3	NULL
'	NULL
primer	NULL
extension	NULL
product	NULL
designated	NULL
as	NULL
+1	NULL
.	NULL

transfection	NULL
assays	NULL
on	NULL
YT	NULL
cells	NULL
.	NULL

A	NULL
series	NULL
of	NULL
promoter	NULL
mutants	NULL
that	NULL
contain	NULL
successive	NULL
deletions	NULL
from	NULL
the	NULL
5	NULL
'	NULL
end	NULL
were	NULL
inserted	NULL
upstream	NULL
of	NULL
a	NULL
firefly	NULL
reporter	NULL
gene	NULL
within	NULL
the	NULL
pGL	NULL
,	NULL
,	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
YT	NULL
cells	NULL
are	NULL
poor	NULL
candidates	NULL
for	NULL
transient	NULL
transfection	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Transient	NULL
cotransfection	NULL
of	NULL
various	NULL
constructed	NULL
promoter	NULL
vectors	NULL
and	NULL
a	NULL
Renilla	NULL
luciferase	NULL
CMV	NULL
promoter-driven	NULL
reporter	NULL
plasmid	NULL
using	NULL
DMRIE-C	NULL
reagent	NULL
were	NULL
conducted	NULL
.	NULL

Using	NULL
a	NULL
ratio	NULL
of	NULL
4.4	NULL
ug	NULL
plasmid	NULL
DNA	NULL
to	NULL
6	NULL
ul	NULL
DMRIE-C	NULL
reagent	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
achieve	NULL
2.5-4	NULL
%	NULL
transfection	NULL
efficiency	NULL
,	NULL
enough	NULL
to	NULL
observe	NULL
measurable	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
firefly	NULL
and	NULL
Renilla	NULL
luciferase	NULL
activity	NULL
was	NULL
then	NULL
measured	NULL
40	NULL
h	NULL
posttransfection	NULL
.	NULL

Transient	NULL
transfections	NULL
of	NULL
these	NULL
5	NULL
'	NULL
deletion	NULL
promoter	NULL
constructs	NULL
into	NULL
YT	NULL
cells	NULL
revealed	NULL
several	NULL
important	NULL
regions	NULL
of	NULL
the	NULL
2B4	NULL
promoter	NULL
that	NULL
regulate	NULL
transcription	NULL
.	NULL

Promoter	NULL
regions	NULL
(	NULL
-	NULL
188	NULL
to	NULL
-80	NULL
)	NULL
and	NULL
(	NULL
-852	NULL
to	NULL
-704	NULL
)	NULL
were	NULL
identified	NULL
to	NULL
have	NULL
a	NULL
positive	NULL
effect	NULL
on	NULL
transcription	NULL
,	NULL
whereas	NULL
the	NULL
promoter	NULL
regions	NULL
(	NULL
-414	NULL
to	NULL
-342	NULL
)	NULL
and	NULL
(	NULL
-704	NULL
to	NULL
-505	NULL
)	NULL
had	NULL
a	NULL
negative	NULL
effect	NULL
.	NULL

Transfections	NULL
conducted	NULL
revealed	NULL
that	NULL
maximal	NULL
luciferase	NULL
activity	NULL
was	NULL
achieved	NULL
with	NULL
the	NULL
promoter	NULL
fragment	NULL
(	NULL
p-342	NULL
)	NULL
produced	NULL
luciferase	NULL
activity	NULL
that	NULL
was	NULL
almost	NULL
4-fold	NULL
higher	NULL
than	NULL
the	NULL
smallest	NULL
promoter	NULL
fragment	NULL
(	NULL
p-80	NULL
)	NULL
,	NULL
which	NULL
we	NULL
designated	NULL
a	NULL
luciferase	NULL
activity	NULL
value	NULL
of	NULL
1	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

When	NULL
the	NULL
promoter	NULL
fragment	NULL
was	NULL
reduced	NULL
further	NULL
from	NULL
(	NULL
-188	NULL
to	NULL
-88	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
,	NULL
there	NULL
was	NULL
a	NULL
significant	NULL
reduction	NULL
of	NULL
activity	NULL
by	NULL
72	NULL
%	NULL
(	NULL
p	NULL
<	NULL
0.001	NULL
)	NULL
.	NULL

These	NULL
results	NULL
reveal	NULL
that	NULL
the	NULL
DNA	NULL
sequences	NULL
between	NULL
-188	NULL
and	NULL
+126	NULL
are	NULL
sufficient	NULL
for	NULL
strong	NULL
promoter	NULL
activity	NULL
in	NULL
YT	NULL
cells	NULL
and	NULL
that	NULL
at	NULL
least	NULL
one	NULL
essential	NULL
DNA	NULL
binding	NULL
element	NULL
is	NULL
located	NULL
within	NULL
the	NULL
-188	NULL
to	NULL
-80	NULL
region	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
AP-1	NULL
binding	NULL
site	NULL
Sequence	NULL
analysis	NULL
of	NULL
the	NULL
DNA	NULL
sequence	NULL
that	NULL
lies	NULL
between	NULL
-188	NULL
and	NULL
-80	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
reveals	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
AP-1	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
relevance	NULL
of	NULL
this	NULL
element	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
YT	NULL
and	NULL
NK-92	NULL
cells	NULL
.	NULL

We	NULL
used	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
[	NULL
Turiferase	NULL
___	NULL
]	NULL
p-l151	NULL
--	NULL
-	NULL
kii	NULL
Luciferase	NULL
___	NULL
]	NULL
p	NULL
#	NULL
52	NULL
enemee	NULL
mm	NULL
__	NULL
L1	NULL
CifOC25E	NULL
p-704	NULL
mmm	NULL
9505	NULL
--	NULL
-	NULL
Pndfaass	NULL
_-	NULL
p44	NULL
--	NULL
_-	NULL
»	NULL
42	NULL
-U	NULL
sig	NULL
o	NULL
TJ	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
p-l115	NULL
p-852	NULL
p-704	NULL
p-505	NULL
p4l4	NULL
p-342	NULL
p-188	NULL
-	NULL
p-80	NULL
Plasmid	NULL
Constructs	NULL
Transfected	NULL
FIGURE	NULL
3	NULL
.	NULL

5'-deletional	NULL
analysis	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
YT	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
series	NULL
of	NULL
5	NULL
'	NULL
promoter	NULL
deletion	NULL
mutants	NULL
in	NULL
the	NULL
pGL	NULL
,	NULL
B	NULL
reporter	NULL
vector	NULL
,	NULL
along	NULL
with	NULL
a	NULL
pRL3-CMV	NULL
control	NULL
plasmid	NULL
.	NULL

Each	NULL
promoter	NULL
fragment	NULL
was	NULL
inserted	NULL
in	NULL
front	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
.	NULL

The	NULL
most	NULL
5	NULL
``	NULL
base	NULL
position	NULL
relative	NULL
to	NULL
+1	NULL
is	NULL
denoted	NULL
on	NULL
the	NULL
right	NULL
.	NULL

Each	NULL
construct	NULL
ends	NULL
at	NULL
the	NULL
+126	NULL
nucleotide	NULL
position	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
complete	NULL
medium	NULL
for	NULL
40	NULL
h.	NULL
B	NULL
,	NULL
Firefly	NULL
luciferase	NULL
activity	NULL
,	NULL
following	NULL
normalization	NULL
to	NULL
Renilla	NULL
luciferase	NULL
activity	NULL
,	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
relative	NULL
luciferase	NULL
activity	NULL
+	NULL
SE	NULL
(	NULL
from	NULL
four	NULL
to	NULL
six	NULL
independent	NULL
experiments	NULL
)	NULL
to	NULL
the	NULL
firefly	NULL
luciferase	NULL
activity	NULL
expressed	NULL
when	NULL
the	NULL
p-80	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
YT	NULL
cells	NULL
.	NULL

The	NULL
normalized	NULL
firefly	NULL
luciferase	NULL
activity	NULL
expressed	NULL
in	NULL
YT	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
p-80	NULL
construct	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1.	NULL
the	NULL
promoter	NULL
sequence	NULL
(	NULL
-111	NULL
to	NULL
-89	NULL
)	NULL
radiolabeled	NULL
with	NULL
[	NULL
y-	NULL
``	NULL
P	NULL
]	NULL
-dATP	NULL
as	NULL
probes	NULL
in	NULL
EMSAs	NULL
.	NULL

Using	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
NK92	NULL
cells	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
reactions	NULL
showed	NULL
multiple	NULL
protein-DNA	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
promoter	NULL
sequence	NULL
(	NULL
-111	NULL
to	NULL
-89	NULL
)	NULL
and	NULL
for	NULL
the	NULL
consensus	NULL
DNA	NULL
binding	NULL
sequence	NULL
for	NULL
AP-1	NULL
were	NULL
used	NULL
as	NULL
cold	NULL
competitors	NULL
at	NULL
100-	NULL
and	NULL
200-fold	NULL
excess	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
labeled	NULL
probe	NULL
used	NULL
,	NULL
only	NULL
one	NULL
band	NULL
was	NULL
competed	NULL
away	NULL
.	NULL

One	NULL
hundred	NULL
and	NULL
two	NULL
hundred	NULL
molar	NULL
excess	NULL
amounts	NULL
of	NULL
unlabeled	NULL
custom	NULL
synthesized	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
consensus	NULL
DNA	NULL
binding	NULL
sequence	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
coding	NULL
for	NULL
the	NULL
h2B4	NULL
promoter	NULL
sequence	NULL
spanning	NULL
-111	NULL
to	NULL
-89	NULL
with	NULL
the	NULL
mutated	NULL
AP-1	NULL
binding	NULL
site	NULL
as	NULL
(	NULL
TGeegCA	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
reactions	NULL
.	NULL

The	NULL
specific	NULL
protein-DNA	NULL
complex	NULL
failed	NULL
to	NULL
be	NULL
competed	NULL
away	NULL
by	NULL
these	NULL
competitors	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

EMSAs	NULL
conducted	NULL
in	NULL
identical	NULL
fashion	NULL
using	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
YT	NULL
cells	NULL
produced	NULL
very	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
upper	NULL
protein-DNA	NULL
binding	NULL
complex	NULL
is	NULL
specific	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
identities	NULL
of	NULL
the	NULL
protein-bound	NULL
fraction	NULL
involved	NULL
in	NULL
the	NULL
upper	NULL
protein-DNA	NULL
complex	NULL
,	NULL
we	NULL
conducted	NULL
the	NULL
DNA	NULL
binding	NULL
reactions	NULL
with	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
NK92	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
panel	NULL
of	NULL
Abs	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
Abs	NULL
specific	NULL
for	NULL
c-Jun	NULL
and	NULL
JunB	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
supershifted	NULL
protein	NULL
DNA	NULL
complex	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
an	NULL
isotype	NULL
control	NULL
Ab	NULL
(	NULL
22B5	NULL
)	NULL
was	NULL
used	NULL
,	NULL
no	NULL
detectable	NULL
additional	NULL
band	NULL
or	NULL
any	NULL
change	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
other	NULL
protein-DNA	NULL
complexes	NULL
6191	NULL
Competitors	NULL
:	NULL
&	NULL
®	NULL
wt	NULL
_	NULL
AP-1	NULL
NF—KF	NULL
Mu	NULL
?	NULL

I	NULL
«	NULL
&	NULL
Ge	NULL
e	NULL
00	NULL
9	NULL
a	NULL
o	NULL
@	NULL
~-	NULL
_	NULL
~	NULL
it	NULL
Cp	NULL
um	NULL
»	NULL
ue	NULL
HPAP	NULL
to	NULL
cn	NULL
5	NULL
,	NULL
N.S	NULL
.	NULL

Free	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
AP-1	NULL
binding	NULL
activity	NULL
at	NULL
-106	NULL
to	NULL
-100	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
detected	NULL
by	NULL
EMSA	NULL
.	NULL

An	NULL
EMSA	NULL
experiment	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
coding	NULL
for	NULL
the	NULL
h2B4	NULL
promoter	NULL
sequence	NULL
spanning	NULL
-111	NULL
to	NULL
-89	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
.	NULL

-ve	NULL
lane	NULL
,	NULL
Binding	NULL
reaction	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NK92	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

+ve	NULL
lane	NULL
,	NULL
Binding	NULL
reaction	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.7	NULL
ug	NULL
NK92	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

Unlabeled	NULL
competitor	NULL
DNAs	NULL
were	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
containing	NULL
NK92	NULL
nuclear	NULL
extract	NULL
at	NULL
100	NULL
and	NULL
200	NULL
molar	NULL
excess	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
competitor	NULL
DNAs	NULL
used	NULL
were	NULL
wt	NULL
(	NULL
wild	NULL
type	NULL
cold	NULL
probe	NULL
)	NULL
,	NULL
AP-1	NULL
(	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
AP-1	NULL
consensus	NULL
binding	NULL
site	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
binding	NULL
site	NULL
)	NULL
,	NULL
and	NULL
Mut	NULL
(	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
h2B4	NULL
promoter	NULL
sequence	NULL
spanning	NULL
-111	NULL
to	NULL
-89	NULL
with	NULL
the	NULL
mutated	NULL
AP-1	NULL
binding	NULL
site	NULL
as	NULL
TGeegCA	NULL
)	NULL
.	NULL
]	NULL

,	NULL
Specific	NULL
AP-1	NULL
protein	NULL
DNA	NULL
interactions	NULL
.	NULL

N.S	NULL
.	NULL

,	NULL
Nonspecific	NULL
bands	NULL
.	NULL

Free	NULL
,	NULL
Unbound	NULL
probe	NULL
.	NULL

could	NULL
be	NULL
detected	NULL
.	NULL

The	NULL
c-Fos	NULL
family	NULL
is	NULL
often	NULL
associated	NULL
with	NULL
the	NULL
Jun	NULL
family	NULL
of	NULL
proteins	NULL
to	NULL
form	NULL
the	NULL
AP-1	NULL
protein	NULL
complex	NULL
(	NULL
31	NULL
)	NULL
.	NULL

When	NULL
we	NULL
incubated	NULL
anti-c-Fos	NULL
Ab	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
reactions	NULL
,	NULL
we	NULL
observed	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
specific	NULL
upper	NULL
protein-DNA	NULL
complex	NULL
severely	NULL
diminished	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
anti-c-Fos	NULL
Ab	NULL
has	NULL
clearly	NULL
shifted	NULL
the	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Ab-mediated	NULL
supershift	NULL
analysis	NULL
in	NULL
EMSAs	NULL
indicate	NULL
that	NULL
AP-1	NULL
interacts	NULL
with	NULL
the	NULL
h2B4	NULL
promoter	NULL
and	NULL
that	NULL
there	NULL
may	NULL
be	NULL
multiple	NULL
forms	NULL
of	NULL
AP-1	NULL
involved	NULL
in	NULL
the	NULL
transcription	NULL
regulation	NULL
of	NULL
the	NULL
A2B4	NULL
gene	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
AP-1	NULL
in	NULL
human	NULL
NK	NULL
cells	NULL
,	NULL
we	NULL
isolated	NULL
untouched	NULL
human	NULL
primary	NULL
cells	NULL
from	NULL
the	NULL
PBMCs	NULL
of	NULL
healthy	NULL
adult	NULL
donors	NULL
by	NULL
cell	NULL
exclusion	NULL
using	NULL
a	NULL
human	NULL
NK	NULL
cell	NULL
isolation	NULL
kit	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
)	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
generated	NULL
from	NULL
the	NULL
isolated	NULL
cells	NULL
and	NULL
used	NULL
in	NULL
EMSAs	NULL
using	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
promoter	NULL
sequence	NULL
(	NULL
-111	NULL
to	NULL
-89	NULL
)	NULL
radiolabeled	NULL
with	NULL
[	NULL
y-	NULL
``	NULL
°P	NULL
]	NULL
dATP	NULL
as	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
DNA-protein	NULL
complex	NULL
suggests	NULL
that	NULL
AP-1	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
primary	NULL
human	NULL
NK	NULL
cells	NULL
interacts	NULL
with	NULL
h2B4	NULL
promoter	NULL
.	NULL

Ab-mediated	NULL
supershift	NULL
analysis	NULL
using	NULL
anti-c-Jun	NULL
,	NULL
anti-JunB	NULL
,	NULL
and	NULL
anti-c-Fos	NULL
further	NULL
confirmed	NULL
that	NULL
AP-1	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
primary	NULL
NK	NULL
cells	NULL
interacts	NULL
with	NULL
the	NULL
h2B4	NULL
promoter	NULL
.	NULL

The	NULL
AP-1	NULL
site	NULL
(	NULL
-106	NULL
to	NULL
-100	NULL
)	NULL
regulates	NULL
the	NULL
h2B4	NULL
promoter	NULL
Upon	NULL
the	NULL
determination	NULL
of	NULL
AP-1	NULL
binding	NULL
to	NULL
the	NULL
promoter	NULL
sequence	NULL
within	NULL
the	NULL
-111	NULL
to	NULL
-89	NULL
sequence	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
and	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
consensus	NULL
DNA	NULL
binding	NULL
site	NULL
sequence	NULL
for	NULL
AP-1	NULL
within	NULL
this	NULL
sequence	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
examine	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
AP-1	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
A2B4	NULL
gene	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
synthesized	NULL
two	NULL
complementary	NULL
oligonucleotides	NULL
that	NULL
code	NULL
for	NULL
the	NULL
promoter	NULL
sequence	NULL
within	NULL
the	NULL
-111	NULL
to	NULL
-89	NULL
sequence	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
with	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
mutated	NULL
from	NULL
TGAGTCA	NULL
to	NULL
TGeegCA	NULL
.	NULL

These	NULL
oligonucleotides	NULL
were	NULL
annealed	NULL
and	NULL
radiolabeled	NULL
with	NULL
[	NULL
y-°P	NULL
]	NULL
dATP	NULL
to	NULL
form	NULL
a	NULL
double-stranded	NULL
EMSA	NULL
probe	NULL
.	NULL

EMSAs	NULL
using	NULL
this	NULL
mutant	NULL
probe	NULL
revealed	NULL
the	NULL
loss	NULL
of	NULL
the	NULL
specific	NULL
protein-DNA	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6192	NULL
TRANSCRIPTIONAL	NULL
REGULATION	NULL
OF	NULL
THE	NULL
HUMAN	NULL
2B4	NULL
(	NULL
CD244	NULL
)	NULL
GENE	NULL
FIGURE	NULL
5	NULL
.	NULL

The	NULL
specific	NULL
binding	NULL
of	NULL
AP-1	NULL
demonstrated	NULL
with	NULL
anti-c-Jun	NULL
and	NULL
anti-c-Fos	NULL
Abs	NULL
in	NULL
EMSA	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
with	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
h2B4	NULL
promoter	NULL
sequence	NULL
spanning	NULL
-111	NULL
to	NULL
-89	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
as	NULL
outlined	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
supershifted	NULL
protein/DNA	NULL
complexes	NULL
.	NULL

-ve	NULL
lane	NULL
,	NULL
Binding	NULL
reaction	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NK92	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

+ve	NULL
lane	NULL
,	NULL
Binding	NULL
reaction	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.7	NULL
ug	NULL
NK92	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL
]	NULL

,	NULL
Where	NULL
the	NULL
AP-1	NULL
protein-DNA	NULL
complex	NULL
is	NULL
absent	NULL
.	NULL

N.S	NULL
.	NULL

,	NULL
Nonspecific	NULL
bands	NULL
.	NULL

Free	NULL
,	NULL
Unbound	NULL
probe	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
AP-1	NULL
DNA	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
h2B4	NULL
promoter	NULL
,	NULL
we	NULL
synthesized	NULL
mutant	NULL
promoter	NULL
constructs	NULL
(	NULL
p-M188	NULL
and	NULL
p-M342	NULL
)	NULL
using	NULL
the	NULL
oligonucleotides	NULL
outlined	NULL
above	NULL
and	NULL
using	NULL
the	NULL
p-188	NULL
and	NULL
p-342	NULL
as	NULL
templates	NULL
in	NULL
multiple	NULL
rounds	NULL
of	NULL
PCR	NULL
(	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
with	NULL
the	NULL
mutant	NULL
promoter	NULL
constructs	NULL
revealed	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
significantly	NULL
reduced	NULL
luciferase	NULL
activity	NULL
(	NULL
p	NULL
<	NULL
0.001	NULL
)	NULL
of	NULL
both	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

The	NULL
data	NULL
suggest	NULL
that	NULL
AP-1	NULL
regulates	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
h2B4	NULL
gene	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
cloned	NULL
the	NULL
h2B4	NULL
promoter	NULL
region	NULL
and	NULL
identified	NULL
a	NULL
significant	NULL
role	NULL
for	NULL
AP-1	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
k2B4	NULL
gene	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
h2B4	NULL
has	NULL
been	NULL
found	NULL
on	NULL
all	NULL
human	NULL
NK	NULL
cells	NULL
,	NULL
a	NULL
subset	NULL
of	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
basophils	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
an	NULL
effort	NULL
to	NULL
identify	NULL
cis-	NULL
and	NULL
trans-acting	NULL
factors	NULL
that	NULL
can	NULL
regulate	NULL
the	NULL
h2B4	NULL
promoter	NULL
,	NULL
we	NULL
isolated	NULL
a	NULL
genomic	NULL
clone	NULL
that	NULL
contained	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

To	NULL
identify	NULL
those	NULL
regions	NULL
in	NULL
the	NULL
promoter	NULL
that	NULL
play	NULL
a	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
A2B4	NULL
gene	NULL
,	NULL
5	NULL
'	NULL
nested	NULL
deletion	NULL
constructs	NULL
were	NULL
created	NULL
and	NULL
inserted	NULL
in	NULL
a	NULL
forward	NULL
orientation	NULL
in	NULL
front	NULL
of	NULL
a	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

Transient	NULL
transfection	NULL
analysis	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
region	NULL
(	NULL
-	NULL
188	NULL
to	NULL
-80	NULL
)	NULL
had	NULL
a	NULL
3.5-fold	NULL
positive	NULL
effect	NULL
on	NULL
transcription	NULL
over	NULL
the	NULL
minimal	NULL
promoter	NULL
(	NULL
-80	NULL
to	NULL
+126	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Several	NULL
other	NULL
regions	NULL
may	NULL
also	NULL
play	NULL
a	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
A2B4	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
-188	NULL
to	NULL
-80	NULL
region	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
is	NULL
a	NULL
putative	NULL
AP-1	NULL
DNA	NULL
binding	NULL
site	NULL
that	NULL
matches	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
AP-1	NULL
.	NULL

Comparison	NULL
to	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
of	NULL
the	NULL
m2B4	NULL
promoter	NULL
shows	NULL
a	NULL
striking	NULL
resemblance	NULL
.	NULL

There	NULL
is	NULL
a	NULL
putative	NULL
AP-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
m2B4	NULL
promoter	NULL
whose	NULL
location	NULL
is	NULL
similar	NULL
relative	NULL
to	NULL
the	NULL
multiple	NULL
initiation	NULL
start	NULL
sites	NULL
as	NULL
we	NULL
have	NULL
found	NULL
in	NULL
the	NULL
h2B4	NULL
promoter	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
mouse	NULL
AP-1	NULL
site	NULL
also	NULL
had	NULL
a	NULL
significant	NULL
positive	NULL
effect	NULL
on	NULL
transcription	NULL
activity	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
an	NULL
effort	NULL
to	NULL
show	NULL
that	NULL
AP-1	NULL
interacts	NULL
with	NULL
the	NULL
-188	NULL
to	NULL
-80	NULL
site	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
using	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
YT	NULL
N.S	NULL
.	NULL

n	NULL
A	NULL
Free	NULL
FIGURE	NULL
6	NULL
.	NULL

AP-1	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
h2B4	NULL
promoter	NULL
detected	NULL
in	NULL
human	NULL
primary	NULL
NK	NULL
cells	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
incubating	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
isolated	NULL
human	NULL
primary	NULL
NK	NULL
cells	NULL
from	NULL
peripheral	NULL
blood	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
h2B4	NULL
promoter	NULL
sequence	NULL
spanning	NULL
-111	NULL
to	NULL
-89	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
.	NULL

Arrow	NULL
indicates	NULL
the	NULL
supershifted	NULL
protein/DNA	NULL
complexes	NULL
.	NULL

-ve	NULL
lane	NULL
,	NULL
Binding	NULL
reaction	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
human	NULL
NK	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

+ve	NULL
lane	NULL
,	NULL
Binding	NULL
reaction	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1.2	NULL
ug	NULL
human	NULL
NK	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL
]	NULL

,	NULL
Where	NULL
the	NULL
AP-1	NULL
protein-DNA	NULL
complex	NULL
is	NULL
absent	NULL
.	NULL

N.S	NULL
.	NULL

,	NULL
Nonspecific	NULL
bands	NULL
.	NULL

Free	NULL
,	NULL
Unbound	NULL
probe	NULL
.	NULL

and	NULL
NK-92	NULL
cells	NULL
and	NULL
labeled	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
-111	NULL
to	NULL
-89	NULL
region	NULL
of	NULL
the	NULL
h2B4	NULL
promoter	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
specific	NULL
and	NULL
nonspecific	NULL
unlabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
competitors	NULL
.	NULL

As	NULL
we	NULL
expected	NULL
,	NULL
only	NULL
those	NULL
competitors	NULL
that	NULL
contained	NULL
an	NULL
AP-1	NULL
binding	NULL
site	NULL
were	NULL
able	NULL
to	NULL
compete	NULL
away	NULL
the	NULL
protein	NULL
DNA	NULL
complex	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Additionally	NULL
,	NULL
heat	NULL
treatment	NULL
of	NULL
nuclear	NULL
protein	NULL
extract	NULL
from	NULL
either	NULL
YT	NULL
or	NULL
NK92	NULL
cells	NULL
at	NULL
85°C	NULL
for	NULL
5	NULL
min	NULL
abolished	NULL
the	NULL
specific	NULL
protein-DNA	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
whether	NULL
the	NULL
protein	NULL
within	NULL
the	NULL
specific	NULL
protein/DNA	NULL
complex	NULL
was	NULL
in	NULL
fact	NULL
AP-1	NULL
,	NULL
we	NULL
conducted	NULL
supershift	NULL
assays	NULL
with	NULL
Abs	NULL
that	NULL
were	NULL
specific	NULL
to	NULL
various	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
.	NULL

The	NULL
AP-1	NULL
transcription	NULL
factor	NULL
consists	NULL
of	NULL
heterodimers	NULL
between	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
of	NULL
proteins	NULL
.	NULL

Interestingly	NULL
,	NULL
both	NULL
Abs	NULL
specific	NULL
for	NULL
c-Jun	NULL
and	NULL
JunB	NULL
partially	NULL
supershifted	NULL
the	NULL
protein/DNA	NULL
complex	NULL
.	NULL

Ab	NULL
specific	NULL
for	NULL
the	NULL
Fos	NULL
family	NULL
supershifted	NULL
the	NULL
entire	NULL
protein/DNA	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
when	NULL
we	NULL
used	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
isolated	NULL
human	NULL
primary	NULL
NK	NULL
cells	NULL
from	NULL
peripheral	NULL
blood	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
there	NULL
are	NULL
multiple	NULL
AP-1	NULL
complexes	NULL
that	NULL
may	NULL
bind	NULL
the	NULL
h2B4	NULL
promoter	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathways	NULL
(	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
,	NULL
MAP/extracellular	NULL
signal-related	NULL
kinase	NULL
kinase	NULL
,	NULL
extracellular	NULL
signal-related	NULL
kinase	NULL
)	NULL
not	NULL
only	NULL
controls	NULL
the	NULL
overall	NULL
levels	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
,	NULL
but	NULL
also	NULL
leads	NULL
to	NULL
the	NULL
phosphorylation	NULL
states	NULL
necessary	NULL
for	NULL
transcriptional	NULL
activity	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
transcription	NULL
of	NULL
the	NULL
h2B4	NULL
gene	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
various	NULL
signaling	NULL
pathways	NULL
that	NULL
can	NULL
stimulate	NULL
the	NULL
various	NULL
MAP	NULL
kinase	NULL
pathways	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
initiation	NULL
of	NULL
transcription	NULL
at	NULL
multiple	NULL
transcription	NULL
start	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
is	NULL
not	NULL
known	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
there	NULL
are	NULL
multiple	NULL
splice	NULL
variants	NULL
of	NULL
2B4	NULL
in	NULL
both	NULL
mice	NULL
and	NULL
human	NULL
(	NULL
18	NULL
,	NULL
23	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
genomic	NULL
structure	NULL
of	NULL
h2B4	NULL
revealed	NULL
that	NULL
the	NULL
different	NULL
transcripts	NULL
are	NULL
derived	NULL
from	NULL
a	NULL
single	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
B	NULL
6193	NULL
@	NULL
<	NULL
&	NULL
<	NULL
AP-1	NULL
binding	NULL
site	NULL
600	NULL
%	NULL
0	NULL
60	NULL
x	NULL
1—11	NULL
,	NULL
GAGTCA	NULL
x	NULL
r	NULL
ceg	NULL
chifzrzzz	NULL
pM	NULL
?	NULL

p-M342	NULL
Luciferase	NULL
p-188	NULL
j	NULL
venues	NULL
CC	NULL
J	NULL
mmmmmmmmmml	NULL
_	NULL
LUCifCT2SC	NULL
p-M188	NULL
mummmmmmen|	NULL
_	NULL
LUCifCTASC	NULL
p-80	NULL
#	NULL
ns	NULL
C	NULL
Free	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
Wild	NULL
type	NULL
Mutant	NULL
Probe	NULL
Probe	NULL
L	NULL
]	NULL
lit	NULL
p-342	NULL
pM342	NULL
p-188	NULL
p-M188	NULL
_	NULL
p-80	NULL
Plasmid	NULL
Constructs	NULL
Transfected	NULL
FIGURE	NULL
7	NULL
.	NULL

The	NULL
mutation	NULL
in	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
inhibits	NULL
AP-1	NULL
protein	NULL
binding	NULL
and	NULL
h2B4	NULL
promoter	NULL
function	NULL
.	NULL

A	NULL
,	NULL
Using	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
coding	NULL
for	NULL
the	NULL
h2B4	NULL
promoter	NULL
sequence	NULL
spanning	NULL
-111	NULL
to	NULL
-89	NULL
with	NULL
the	NULL
mutated	NULL
AP-1	NULL
binding	NULL
site	NULL
as	NULL
TGeegCA	NULL
in	NULL
EMSAs	NULL
with	NULL
NK92	NULL
nuclear	NULL
extracts	NULL
,	NULL
specific	NULL
AP-1	NULL
protein	NULL
binding	NULL
was	NULL
abolished	NULL
.	NULL

-ve	NULL
lane	NULL
,	NULL
Binding	NULL
reaction	NULL
performed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NK92	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

+ve	NULL
lane	NULL
,	NULL
Binding	NULL
reaction	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2.7	NULL
ug	NULL
NK92	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL
]	NULL

,	NULL
Where	NULL
the	NULL
AP-1	NULL
protein-DNA	NULL
complex	NULL
is	NULL
absent	NULL
.	NULL

N.	NULL
S.	NULL
,	NULL
Nonspecific	NULL
bands	NULL
.	NULL

Free	NULL
,	NULL
Unbound	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
AP-1	NULL
binding	NULL
site	NULL
mutant	NULL
constructs	NULL
were	NULL
created	NULL
and	NULL
used	NULL
in	NULL
the	NULL
transient	NULL
promoter	NULL
reporter	NULL
assay	NULL
.	NULL

Lower	NULL
case	NULL
letters	NULL
are	NULL
nucleotides	NULL
used	NULL
to	NULL
mutate	NULL
the	NULL
underlined	NULL
letters	NULL
within	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
.	NULL

Each	NULL
promoter	NULL
fragment	NULL
was	NULL
inserted	NULL
in	NULL
front	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
complete	NULL
medium	NULL
for	NULL
40	NULL
h.	NULL
C	NULL
,	NULL
Firefly	NULL
luciferase	NULL
activity	NULL
,	NULL
following	NULL
normalization	NULL
to	NULL
Renilla	NULL
luciferase	NULL
activity	NULL
,	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
relative	NULL
luciferase	NULL
activity	NULL
+	NULL
SE	NULL
(	NULL
from	NULL
four	NULL
to	NULL
six	NULL
independent	NULL
experiments	NULL
)	NULL
to	NULL
the	NULL
firefly	NULL
luciferase	NULL
activity	NULL
expressed	NULL
when	NULL
the	NULL
p-80	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
YT	NULL
cells	NULL
.	NULL

The	NULL
normalized	NULL
firefly	NULL
luciferase	NULL
activity	NULL
expressed	NULL
in	NULL
YT	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
p-80	NULL
construct	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.001	NULL
(	NULL
from	NULL
the	NULL
respective	NULL
wild-type	NULL
counterpart	NULL
)	NULL
.	NULL

gene	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
A2B4	NULL
gene	NULL
promoter	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
the	NULL
production	NULL
of	NULL
different	NULL
splice	NULL
variants	NULL
.	NULL

In	NULL
the	NULL
mouse	NULL
,	NULL
the	NULL
splice	NULL
variants	NULL
give	NULL
rise	NULL
to	NULL
different	NULL
isoforms	NULL
of	NULL
2B4	NULL
that	NULL
display	NULL
opposing	NULL
signals	NULL
to	NULL
NK	NULL
cells	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
functional	NULL
roles	NULL
of	NULL
h2B4	NULL
splice	NULL
variants	NULL
are	NULL
not	NULL
known	NULL
(	NULL
18	NULL
,	NULL
23	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
multiple	NULL
transcription	NULL
start	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
h2B4	NULL
promoter	NULL
may	NULL
be	NULL
differentially	NULL
used	NULL
under	NULL
different	NULL
conditions	NULL
of	NULL
activation	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
h2B4	NULL
contains	NULL
four	NULL
novel	NULL
tyrosine-based	NULL
motifs	NULL
(	NULL
1	NULL
)	NULL
.	NULL

These	NULL
motifs	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
found	NULL
on	NULL
other	NULL
CD2	NULL
subfamily	NULL
members	NULL
including	NULL
SLAM	NULL
,	NULL
Ly9	NULL
,	NULL
CS1	NULL
,	NULL
and	NULL
CD84	NULL
(	NULL
35-38	NULL
)	NULL
and	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
protein	NULL
tyrosine	NULL
phos-phatase	NULL
,	NULL
SHP-2	NULL
and	NULL
the	NULL
Src	NULL
homology-2	NULL
domain	NULL
containing	NULL
adaptor	NULL
molecule	NULL
,	NULL
SAP	NULL
(	NULL
14	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
SAP	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
genetic	NULL
defect	NULL
in	NULL
XLPD	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Although	NULL
h2B4	NULL
on	NULL
the	NULL
NK	NULL
cells	NULL
of	NULL
these	NULL
patients	NULL
are	NULL
normal	NULL
,	NULL
2B4	NULL
could	NULL
not	NULL
interact	NULL
with	NULL
the	NULL
mutant	NULL
SAP	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Immunoprecipitations	NULL
of	NULL
h2B4	NULL
from	NULL
NK	NULL
cells	NULL
from	NULL
these	NULL
patients	NULL
coprecipitated	NULL
SHP-1	NULL
.	NULL

This	NULL
is	NULL
contrary	NULL
to	NULL
previous	NULL
reports	NULL
that	NULL
showed	NULL
SHP-2	NULL
,	NULL
not	NULL
SHP-1	NULL
is	NULL
able	NULL
to	NULL
associate	NULL
with	NULL
the	NULL
h2B4	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
h2B4	NULL
has	NULL
been	NULL
found	NULL
to	NULL
localize	NULL
to	NULL
the	NULL
glycolipid-enriched	NULL
microdomains	NULL
and	NULL
to	NULL
associate	NULL
with	NULL
another	NULL
adaptor	NULL
molecule	NULL
,	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
constitutively	NULL
associated	NULL
to	NULL
2B4	NULL
,	NULL
and	NULL
that	NULL
engagement	NULL
of	NULL
2B4	NULL
results	NULL
in	NULL
the	NULL
recruitment	NULL
of	NULL
other	NULL
signaling	NULL
molecules	NULL
including	NULL
phospholipase	NULL
Cy	NULL
and	NULL
Grb2	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
that	NULL
2B4	NULL
signaling	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
NK	NULL
inhibitory	NULL
receptors	NULL
engaged	NULL
by	NULL
their	NULL
MHC	NULL
class	NULL
I	NULL
ligands	NULL
on	NULL
resistant	NULL
cells	NULL
(	NULL
41	NULL
)	NULL
.	NULL

This	NULL
is	NULL
caused	NULL
by	NULL
the	NULL
recruitment	NULL
of	NULL
SHP-1	NULL
,	NULL
which	NULL
blocks	NULL
phosphory-	NULL
lation	NULL
of	NULL
the	NULL
2B4	NULL
cytoplasmic	NULL
tail	NULL
.	NULL

Although	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
signaling	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
h2B4	NULL
uses	NULL
to	NULL
increase	NULL
cytolytic	NULL
activity	NULL
and	NULL
cytokine	NULL
release	NULL
is	NULL
incomplete	NULL
,	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
transcriptional	NULL
events	NULL
are	NULL
necessary	NULL
for	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
found	NULL
NK	NULL
cell	NULL
treatment	NULL
of	NULL
inhibitors	NULL
of	NULL
the	NULL
AP-1	NULL
pathway	NULL
prevented	NULL
natural	NULL
cytotoxicity	NULL
of	NULL
susceptible	NULL
target	NULL
tumor	NULL
cells	NULL
by	NULL
NK	NULL
cells	NULL
(	NULL
42	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
h2B4	NULL
stimulation	NULL
of	NULL
NK	NULL
cells	NULL
triggers	NULL
many	NULL
events	NULL
that	NULL
may	NULL
be	NULL
controlled	NULL
through	NULL
transcription	NULL
,	NULL
including	NULL
an	NULL
increase	NULL
in	NULL
transcription	NULL
of	NULL
IFN-y	NULL
and	NULL
MMP-2	NULL
(	NULL
8	NULL
,	NULL
43	NULL
)	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
and	NULL
begun	NULL
to	NULL
characterize	NULL
the	NULL
h2B4	NULL
,	NULL
which	NULL
modulates	NULL
NK	NULL
cell	NULL
functions	NULL
(	NULL
1	NULL
,	NULL
8	NULL
)	NULL
.	NULL

It	NULL
would	NULL
be	NULL
very	NULL
interesting	NULL
to	NULL
investigate	NULL
the	NULL
role	NULL
that	NULL
AP-1	NULL
may	NULL
play	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
of	NULL
h2B4	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

AP-1	NULL
has	NULL
been	NULL
found	NULL
to	NULL
transcrip-tionally	NULL
regulate	NULL
many	NULL
immune	NULL
response	NULL
genes	NULL
including	NULL
IFN-y	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
,	NULL
IL-3	NULL
(	NULL
46	NULL
)	NULL
,	NULL
granzyme	NULL
B	NULL
(	NULL
47	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
,	NULL
IL-5	NULL
(	NULL
50	NULL
)	NULL
,	NULL
and	NULL
now	NULL
A2B4	NULL
.	NULL

Many	NULL
studies	NULL
done	NULL
on	NULL
various	NULL
NK	NULL
cell	NULL
stimulation	NULL
pathways	NULL
have	NULL
found	NULL
involvement	NULL
of	NULL
AP-1	NULL
and	NULL
the	NULL
MAP	NULL
kinase	NULL
pathways	NULL
(	NULL
50-59	NULL
)	NULL
.	NULL

Thus	NULL
it	NULL
appears	NULL
that	NULL
AP-1	NULL
may	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
signaling	NULL
activation	NULL
of	NULL
NK	NULL
cells	NULL
and	NULL
that	NULL
h2B4	NULL
gene	NULL
-1115	NULL
-852	NULL
-	NULL
-704	NULL
-505	NULL
-414	NULL
-342	NULL
-188	NULL
-80	NULL
+|_l	NULL
>	NULL
[	NULL
-T	NULL
OH	NULL
~~	NULL
|	NULL
|	NULL
_+	NULL
+126	NULL
FIGURE	NULL
8	NULL
.	NULL

Schematic	NULL
diagram	NULL
showing	NULL
the	NULL
regulating	NULL
regions	NULL
of	NULL
the	NULL
h2B4	NULL
gene	NULL
.	NULL

+	NULL
and	NULL
-	NULL
,	NULL
Positive	NULL
and	NULL
negative	NULL
cis-acting	NULL
sequences	NULL
active	NULL
in	NULL
YT	NULL
cells	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
their	NULL
relative	NULL
strength	NULL
.	NULL

Numbers	NULL
indicate	NULL
nucleotide	NULL
positions	NULL
defining	NULL
the	NULL
regions	NULL
relative	NULL
to	NULL
the	NULL
start	NULL
of	NULL
transcription	NULL
(	NULL
+1	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6194	NULL
expression	NULL
,	NULL
regulated	NULL
through	NULL
AP-1	NULL
,	NULL
may	NULL
be	NULL
controlled	NULL
via	NULL
many	NULL
different	NULL
pathways	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Kent	NULL
S.	NULL
Boles	NULL
for	NULL
insightful	NULL
discussions	NULL
and	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
Vinay	NULL
Kumar	NULL
(	NULL
University	NULL
of	NULL
Chicago	NULL
Medical	NULL
School	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
Dr.	NULL
Michael	NULL
Bennett	NULL
(	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
)	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
mAb	NULL
22B5	NULL
.	NULL

References	NULL
1	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

Boles	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
H.	NULL
Nakajima	NULL
,	NULL
M.	NULL
Colonna	NULL
,	NULL
S.	NULL
S.	NULL
Chuang	NULL
,	NULL
S.	NULL
E.	NULL
Stepp	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
V.	NULL
Kumar	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Mathew	NULL
.	NULL

1999	NULL
.	NULL

Molecular	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
human	NULL
natural	NULL
killer	NULL
cell	NULL
receptor	NULL
homologous	NULL
to	NULL
mouse	NULL
2B4	NULL
.	NULL

Tissue	NULL
Antigens	NULL
54:27.	NULL
.	NULL

Nakajima	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Cella	NULL
,	NULL
H.	NULL
Langen	NULL
,	NULL
A.	NULL
Friedlein	NULL
,	NULL
and	NULL
M.	NULL
Colonna	NULL
.	NULL

1999	NULL
.	NULL

Acti-	NULL
vating	NULL
interactions	NULL
in	NULL
human	NULL
NK	NULL
cell	NULL
recognition	NULL
:	NULL
the	NULL
role	NULL
of	NULL
2B4-CD48	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

29:1676.	NULL
.	NULL

Nakajima	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
M.	NULL
Colonna	NULL
.	NULL

2000	NULL
.	NULL

2B4	NULL
:	NULL
an	NULL
NK	NULL
cell	NULL
activating	NULL
receptor	NULL
with	NULL
unique	NULL
specificity	NULL
and	NULL
signal	NULL
transduction	NULL
mechanism	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

61:39.	NULL
.	NULL

Garni-Wagner	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
A.	NULL
Purohit	NULL
,	NULL
P.	NULL
A.	NULL
Mathew	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
and	NULL
V.	NULL
Kumar	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
novel	NULL
function-associated	NULL
molecule	NULL
related	NULL
to	NULL
non-MHC-restricted	NULL
cytotoxicity	NULL
mediated	NULL
by	NULL
activated	NULL
natural	NULL
killer	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:60.	NULL
.	NULL

Mathew	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Garni-Wagner	NULL
,	NULL
K.	NULL
Land	NULL
,	NULL
A.	NULL
Takashima	NULL
,	NULL
E.	NULL
Stoneman	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
and	NULL
V.	NULL
Kumar	NULL
.	NULL

1993	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
2B4	NULL
gene	NULL
encoding	NULL
a	NULL
molecule	NULL
associated	NULL
with	NULL
non-MHC-restricted	NULL
killing	NULL
mediated	NULL
by	NULL
activated	NULL
natural	NULL
killer	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:5328.	NULL
.	NULL

Schubmachers	NULL
,	NULL
G.	NULL
,	NULL
K.	NULL
Ariizumi	NULL
,	NULL
P.	NULL
A.	NULL
Mathew	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
V.	NULL
Kumar	NULL
,	NULL
and	NULL
A.	NULL
Takashima	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
murine	NULL
epidermal	NULL
48	NULL
T	NULL
cells	NULL
through	NULL
surface	NULL
2B4	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:1117.	NULL
.	NULL

Schubmachers	NULL
,	NULL
G.	NULL
,	NULL
K.	NULL
Ariizumi	NULL
,	NULL
P.	NULL
A.	NULL
Mathew	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
V.	NULL
Kumar	NULL
,	NULL
and	NULL
A.	NULL
Takashima	NULL
.	NULL

1995	NULL
.	NULL

2B4	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
super-family	NULL
,	NULL
is	NULL
expressed	NULL
on	NULL
murine	NULL
dendritic	NULL
epidermal	NULL
T	NULL
cells	NULL
and	NULL
plays	NULL
a	NULL
functional	NULL
role	NULL
in	NULL
their	NULL
killing	NULL
of	NULL
skin	NULL
tumors	NULL
.	NULL

J	NULL
.	NULL

Invest	NULL
.	NULL

Dermatol	NULL
.	NULL

105:592.	NULL
.	NULL

Chuang	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
M.	NULL
H.	NULL
Kim	NULL
,	NULL
L.	NULL
A.	NULL
Johnson	NULL
,	NULL
P.	NULL
Albertsson	NULL
,	NULL
R.	NULL
P.	NULL
Kitson	NULL
,	NULL
U.	NULL
Nannmark	NULL
,	NULL
R.	NULL
H.	NULL
Goldfarb	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Mathew	NULL
.	NULL

2000	NULL
.	NULL

2B4	NULL
stimulation	NULL
of	NULL
YT	NULL
cells	NULL
induces	NULL
natural	NULL
killer	NULL
cell	NULL
cytolytic	NULL
function	NULL
and	NULL
invasiveness	NULL
.	NULL

Immunology	NULL
100:378.	NULL
.	NULL

Brown	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
K.	NULL
Boles	NULL
,	NULL
P.	NULL
A.	NULL
van	NULL
der	NULL
Merwe	NULL
,	NULL
V.	NULL
Kumar	NULL
,	NULL
P.	NULL
A.	NULL
Mathew	NULL
,	NULL
and	NULL
A.	NULL
N.	NULL
Barclay	NULL
.	NULL

1998	NULL
.	NULL

2B4	NULL
,	NULL
the	NULL
natural	NULL
killer	NULL
and	NULL
T	NULL
cell	NULL
immunoglobulin	NULL
superfamily	NULL
surface	NULL
protein	NULL
,	NULL
is	NULL
a	NULL
ligand	NULL
for	NULL
CD48	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:2083	NULL
.	NULL

Sivori	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Parolini	NULL
,	NULL
M.	NULL
Falco	NULL
,	NULL
E.	NULL
Marcenaro	NULL
,	NULL
R.	NULL
Biassoni	NULL
,	NULL
C.	NULL
Bottino	NULL
,	NULL
L.	NULL
Moretta	NULL
,	NULL
and	NULL
A.	NULL
Moretta	NULL
.	NULL

2000	NULL
.	NULL

2B4	NULL
functions	NULL
as	NULL
a	NULL
co-receptor	NULL
in	NULL
human	NULL
NK	NULL
cell	NULL
activation	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

30:787	NULL
.	NULL

Tangye	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
S.	NULL
Lazetic	NULL
,	NULL
E.	NULL
Woollatt	NULL
,	NULL
G.	NULL
R.	NULL
Sutherland	NULL
,	NULL
L.	NULL
L.	NULL
Lanier	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Phillips	NULL
.	NULL

1999	NULL
.	NULL

Cutting	NULL
edge	NULL
:	NULL
human	NULL
2B4	NULL
,	NULL
an	NULL
activating	NULL
NK	NULL
cell	NULL
receptor	NULL
,	NULL
recruits	NULL
the	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
SHP-2	NULL
and	NULL
the	NULL
adaptor	NULL
signaling	NULL
protein	NULL
SAP	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:6981	NULL
.	NULL

Nichols	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
D.	NULL
P.	NULL
Harkin	NULL
,	NULL
S.	NULL
Levitz	NULL
,	NULL
M.	NULL
Krainer	NULL
,	NULL
K.	NULL
A.	NULL
Kolquist	NULL
,	NULL
C.	NULL
Genovese	NULL
,	NULL
A.	NULL
Bernard	NULL
,	NULL
M.	NULL
Ferguson	NULL
,	NULL
L.	NULL
Zuo	NULL
,	NULL
E.	NULL
Snyder	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Inactivating	NULL
mutations	NULL
in	NULL
an	NULL
SH2	NULL
domain-encoding	NULL
gene	NULL
in	NULL
X-linked	NULL
lymphoproliferative	NULL
syndrome	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:13765	NULL
.	NULL

Coffey	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
R.	NULL
A.	NULL
Brooksbank	NULL
,	NULL
O.	NULL
Brandau	NULL
,	NULL
T.	NULL
Oohashi	NULL
,	NULL
G.	NULL
R.	NULL
Howell	NULL
,	NULL
J.	NULL
M.	NULL
Bye	NULL
,	NULL
A.	NULL
P.	NULL
Cahn	NULL
,	NULL
J.	NULL
Durham	NULL
,	NULL
P.	NULL
Heath	NULL
,	NULL
P.	NULL
Wray	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Host	NULL
response	NULL
to	NULL
EBV	NULL
infection	NULL
in	NULL
X-linked	NULL
lymphoproliferative	NULL
disease	NULL
results	NULL
from	NULL
mutations	NULL
in	NULL
an	NULL
SH2-domain	NULL
encoding	NULL
gene	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

20:129	NULL
,	NULL
Sayos	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Wu	NULL
,	NULL
M.	NULL
Morra	NULL
,	NULL
N.	NULL
Wang	NULL
,	NULL
X.	NULL
Zhang	NULL
,	NULL
D.	NULL
Allen	NULL
,	NULL
S.	NULL
van	NULL
Schaik	NULL
,	NULL
L.	NULL
Notarangelo	NULL
,	NULL
R.	NULL
Geha	NULL
,	NULL
M.	NULL
G.	NULL
Roncarolo	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
X-linked	NULL
lympho-proliferative-disease	NULL
gene	NULL
product	NULL
SAP	NULL
regulates	NULL
signals	NULL
induced	NULL
through	NULL
the	NULL
co-receptor	NULL
SLAM	NULL
.	NULL

Nature	NULL
395:462	NULL
.	NULL

Tangye	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
J.	NULL
H.	NULL
Phillips	NULL
,	NULL
L.	NULL
L.	NULL
Lanier	NULL
,	NULL
and	NULL
K.	NULL
E.	NULL
Nichols	NULL
.	NULL

2000	NULL
.	NULL

Functional	NULL
requirement	NULL
for	NULL
SAP	NULL
in	NULL
2B4-mediated	NULL
activation	NULL
of	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
as	NULL
revealed	NULL
by	NULL
the	NULL
X-linked	NULL
lymphoproliferative	NULL
syndrome	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

165:2932	NULL
.	NULL

Benoit	NULL
,	NULL
L.	NULL
,	NULL
X.	NULL
Wang	NULL
,	NULL
H.	NULL
F.	NULL
Pabst	NULL
,	NULL
J.	NULL
Dutz	NULL
,	NULL
and	NULL
R.	NULL
Tan	NULL
.	NULL

2000	NULL
.	NULL

Defective	NULL
NK	NULL
cell	NULL
activation	NULL
in	NULL
X-linked	NULL
lymphoproliferative	NULL
disease	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

165:3549	NULL
.	NULL

Nakajima	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Cella	NULL
,	NULL
A.	NULL
Bouchon	NULL
,	NULL
H.	NULL
L.	NULL
Grierson	NULL
,	NULL
J.	NULL
Lewis	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
J.	NULL
I.	NULL
Cohen	NULL
,	NULL
and	NULL
M.	NULL
Colonna	NULL
.	NULL

2000	NULL
.	NULL

Patients	NULL
with	NULL
X-linked	NULL
lymphoproliferative	NULL
disease	NULL
have	NULL
a	NULL
defect	NULL
in	NULL
2B4	NULL
receptor-mediated	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

30:3309	NULL
.	NULL

Parolini	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Boittino	NULL
,	NULL
M.	NULL
Falco	NULL
,	NULL
R.	NULL
Augugliaro	NULL
,	NULL
S.	NULL
Giliani	NULL
,	NULL
R.	NULL
Franceschini	NULL
,	NULL
H.	NULL
D.	NULL
Ochs	NULL
,	NULL
H.	NULL
Wolf	NULL
,	NULL
J.	NULL
Y.	NULL
Bonnefoy	NULL
,	NULL
R.	NULL
Biassoni	NULL
,	NULL
et	NULL
al	NULL
.	NULL

2000	NULL
.	NULL

X-linked	NULL
lymphoproliferative	NULL
disease	NULL
:	NULL
2B4	NULL
molecules	NULL
displaying	NULL
inhibitory	NULL
rather	NULL
than	NULL
activating	NULL
function	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
to	NULL
kill	NULL
Epstein-Barr	NULL
virus-infected	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

192:337	NULL
.	NULL

Peritt	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
A.	NULL
Sesolk-Pizzini	NULL
,	NULL
R.	NULL
Schretzenmair	NULL
,	NULL
R.	NULL
R.	NULL
Macgregor	NULL
,	NULL
N.	NULL
M.	NULL
Valiante	NULL
,	NULL
X.	NULL
Tu	NULL
,	NULL
G.	NULL
Trinchieri	NULL
,	NULL
and	NULL
M.	NULL
Kamoun	NULL
.	NULL

1999	NULL
.	NULL

C1.7	NULL
antigen	NULL
expression	NULL
on	NULL
CD8*	NULL
T	NULL
cells	NULL
is	NULL
activation	NULL
dependent	NULL
:	NULL
increased	NULL
proportion	NULL
of	NULL
C1.7	NULL
``	NULL
CD8*	NULL
T	NULL
cells	NULL
in	NULL
HIV-1-infected	NULL
patients	NULL
with	NULL
progressing	NULL
disease	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:7563	NULL
.	NULL

Kumaresan	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
V.	NULL
T.	NULL
Huynh	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Mathew	NULL
.	NULL

2000	NULL
.	NULL

Polymorphism	NULL
in	NULL
the	NULL
2B4	NULL
gene	NULL
of	NULL
inbred	NULL
mouse	NULL
strains	NULL
.	NULL

Immunogenetics	NULL
51:758	NULL
.	NULL

Chuang	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Y.	NULL
Lee	NULL
,	NULL
S.	NULL
E.	NULL
Stepp	NULL
,	NULL
P.	NULL
R.	NULL
Kumaresan	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Mathew	NULL
.	NULL

1999	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
murine	NULL
natural	NULL
killer	NULL
cell	NULL
receptor	NULL
2B4	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1447:244	NULL
.	NULL

Lee	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Clark	NULL
.	NULL

1997	NULL
.	NULL

High-yield	NULL
method	NULL
for	NULL
isolation	NULL
of	NULL
A	NULL
DNA	NULL
.	NULL

BioTechniques	NULL
23:598	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

TRANSCRIPTIONAL	NULL
REGULATION	NULL
OF	NULL
THE	NULL
HUMAN	NULL
2B4	NULL
(	NULL
CD244	NULL
)	NULL
GENE	NULL
Kumaresan	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Mathew	NULL
.	NULL

2000	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
human	NULL
natural	NULL
killer	NULL
cell	NULL
receptor	NULL
2B4	NULL
gene	NULL
and	NULL
identification	NULL
of	NULL
a	NULL
novel	NULL
alternative	NULL
transcript	NULL
.	NULL

Immunogenetics	NULL
51:987	NULL
.	NULL

Chuang	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
H.	NULL
Zhuang	NULL
,	NULL
S.	NULL
R.	NULL
Reisher	NULL
,	NULL
S.	NULL
I.	NULL
Feinstein	NULL
,	NULL
and	NULL
H.	NULL
K.	NULL
Das	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
apolipoprotein	NULL
B-100	NULL
gene	NULL
:	NULL
identification	NULL
of	NULL
cis-acting	NULL
elements	NULL
in	NULL
the	NULL
first	NULL
nontranslated	NULL
exon	NULL
of	NULL
the	NULL
human	NULL
apolipoprotein	NULL
B-100	NULL
gene	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
215:394	NULL
.	NULL

Chuang	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
and	NULL
H.	NULL
K.	NULL
Das	NULL
.	NULL

1999	NULL
.	NULL

A	NULL
single	NULL
in	NULL
vitro	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
first	NULL
non-translated	NULL
exon	NULL
silences	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
apolipoprotein	NULL
B	NULL
gene	NULL
in	NULL
HepG2	NULL
cells	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1436:600	NULL
.	NULL

Chen	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
G.	NULL
Liang	NULL
,	NULL
J.	NULL
Whelan	NULL
,	NULL
and	NULL
T.	NULL
Hai	NULL
.	NULL

1994	NULL
.	NULL

ATF3	NULL
and	NULL
ATF3	NULL
8	NULL
zip	NULL
:	NULL
transcriptional	NULL
repression	NULL
versus	NULL
activation	NULL
by	NULL
alternatively	NULL
spliced	NULL
isoforms	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:15819	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1977	NULL
.	NULL

A	NULL
new	NULL
method	NULL
for	NULL
sequencing	NULL
DNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
74:560	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Chuang	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
D.	NULL
Banerjee	NULL
,	NULL
and	NULL
H.	NULL
K.	NULL
Das	NULL
.	NULL

1999	NULL
.	NULL

Purified	NULL
apolipoprotein	NULL
B	NULL
gene	NULL
regulatory	NULL
factor-3	NULL
is	NULL
DNA	NULL
topoisomerase	NULL
I.	NULL
Kur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

263:773	NULL
.	NULL

Nagashima	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Mailliard	NULL
,	NULL
Y.	NULL
Kashii	NULL
,	NULL
T.	NULL
E.	NULL
Reichert	NULL
,	NULL
R.	NULL
B.	NULL
Herberman	NULL
,	NULL
P.	NULL
Robbins	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Whiteside	NULL
.	NULL

1998	NULL
.	NULL

Stable	NULL
transduction	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
into	NULL
human	NULL
natural	NULL
killer	NULL
cell	NULL
lines	NULL
and	NULL
their	NULL
phenotypic	NULL
and	NULL
functional	NULL
characterization	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Blood	NULL
91:3850	NULL
.	NULL

Wisdom	NULL
,	NULL
R.	NULL
1999	NULL
.	NULL

AP-1	NULL
:	NULL
one	NULL
switch	NULL
for	NULL
many	NULL
signals	NULL
.	NULL

Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

253:180	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
,	NULL
Z.	NULL
Liu	NULL
,	NULL
and	NULL
E.	NULL
Zandi	NULL
.	NULL

1997	NULL
.	NULL

AP-1	NULL
function	NULL
and	NULL
regulation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

9:240	NULL
.	NULL

Stepp	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
J.	NULL
D.	NULL
Schatzle	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
V.	NULL
Kumar	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Mathew	NULL
.	NULL

1999	NULL
.	NULL

Gene	NULL
structure	NULL
of	NULL
the	NULL
murine	NULL
NK	NULL
cell	NULL
receptor	NULL
2B4	NULL
:	NULL
presence	NULL
of	NULL
two	NULL
alternatively	NULL
spliced	NULL
isoforms	NULL
with	NULL
distinct	NULL
cytoplasmic	NULL
domains	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

29:2392	NULL
.	NULL

Schatzle	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
S.	NULL
Sheu	NULL
,	NULL
S.	NULL
E.	NULL
Stepp	NULL
,	NULL
P.	NULL
A.	NULL
Mathew	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
and	NULL
V.	NULL
Kumar	NULL
.	NULL

1999	NULL
.	NULL

Characterization	NULL
of	NULL
inhibitory	NULL
and	NULL
stimulatory	NULL
forms	NULL
of	NULL
the	NULL
murine	NULL
natural	NULL
killer	NULL
cell	NULL
receptor	NULL
2B4	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96:3870	NULL
.	NULL

Cocks	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
C.	NULL
C.	NULL
Chang	NULL
,	NULL
J.	NULL
M.	NULL
Carballido	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
,	NULL
and	NULL
G.	NULL
Aversa	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
receptor	NULL
involved	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
376:260.	NULL
de	NULL
la	NULL
Fuente	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
P.	NULL
Pizcueta	NULL
,	NULL
M.	NULL
Nadal	NULL
,	NULL
J.	NULL
Bosch	NULL
,	NULL
and	NULL
P.	NULL
Engel	NULL
.	NULL

1997	NULL
.	NULL

CD84	NULL
leukocyte	NULL
antigen	NULL
is	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
Ig	NULL
superfamily	NULL
.	NULL

Blood	NULL
90:2398	NULL
.	NULL

Sandrin	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
M.	NULL
M.	NULL
Henning	NULL
,	NULL
M.	NULL
F.	NULL
Lo	NULL
,	NULL
E.	NULL
Baker	NULL
,	NULL
G.	NULL
R.	NULL
Sutherland	NULL
,	NULL
and	NULL
I.	NULL
F.	NULL
McKenzie	NULL
.	NULL

1996	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
cDNA	NULL
clones	NULL
for	NULL
Humly9	NULL
:	NULL
the	NULL
human	NULL
homologue	NULL
of	NULL
mouse	NULL
Ly9	NULL
.	NULL

Immunogenetics	NULL
43:13	NULL
.	NULL

Boles	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Mathew	NULL
.	NULL

2001	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
CS1	NULL
,	NULL
a	NULL
novel	NULL
human	NULL
natural	NULL
killer	NULL
cell	NULL
receptor	NULL
belonging	NULL
to	NULL
the	NULL
CD2	NULL
subset	NULL
of	NULL
the	NULL
immunoglobulin	NULL
superfamily	NULL
.	NULL

Immunogenetics	NULL
52:302	NULL
.	NULL

Klem	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
V.	NULL
Kumar	NULL
,	NULL
and	NULL
J.	NULL
Schatzle	NULL
.	NULL

2000	NULL
.	NULL

The	NULL
NK	NULL
receptor	NULL
,	NULL
2B4	NULL
,	NULL
is	NULL
constitutively	NULL
localized	NULL
in	NULL
glycolipid-enriched	NULL
microdomains	NULL
and	NULL
associates	NULL
with	NULL
LAT	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

14	NULL
:	NULL
A1026	NULL
.	NULL

Bottino	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
Augugliaro	NULL
,	NULL
R.	NULL
Castriconi	NULL
,	NULL
M.	NULL
Nanni	NULL
,	NULL
R.	NULL
Biassoni	NULL
,	NULL
L.	NULL
Moretta	NULL
,	NULL
and	NULL
A.	NULL
Moretta	NULL
.	NULL

2000	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
molecular	NULL
mechanism	NULL
involved	NULL
in	NULL
2B4-mediated	NULL
NK	NULL
cell	NULL
activation	NULL
:	NULL
evidence	NULL
that	NULL
human	NULL
2B4	NULL
is	NULL
physically	NULL
and	NULL
functionally	NULL
associated	NULL
with	NULL
the	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

30:3718	NULL
.	NULL

Watzl	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
C.	NULL
Stebbins	NULL
,	NULL
and	NULL
E.	NULL
O	NULL
.	NULL

Long	NULL
.	NULL

2000	NULL
.	NULL

NK	NULL
cell	NULL
inhibitory	NULL
receptors	NULL
prevent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
activation	NULL
receptor	NULL
2B4	NULL
(	NULL
CD244	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

165:3545	NULL
.	NULL

Bemard	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
Cambiaggi	NULL
,	NULL
S.	NULL
Guia	NULL
,	NULL
F.	NULL
Bertucci	NULL
,	NULL
S.	NULL
Granjeaud	NULL
,	NULL
R.	NULL
Tagett	NULL
,	NULL
C.	NULL
N'guyen	NULL
,	NULL
B.	NULL
R.	NULL
Jordan	NULL
,	NULL
and	NULL
E.	NULL
Vivier	NULL
.	NULL

1999	NULL
.	NULL

Engagement	NULL
of	NULL
natural	NULL
cytotoxicity	NULL
programs	NULL
regulates	NULL
AP-1	NULL
expression	NULL
in	NULL
the	NULL
NKL	NULL
human	NULL
NK	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:4062	NULL
.	NULL

Johnson	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
R.	NULL
H.	NULL
Goldfarb	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Mathew	NULL
.	NULL

2000	NULL
.	NULL

Regulation	NULL
of	NULL
IFN-y	NULL
production	NULL
following	NULL
2B4	NULL
activation	NULL
in	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
Vivo	NULL
14:625.	NULL
.	NULL

Penix	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
M.	NULL
T.	NULL
Sweetser	NULL
,	NULL
W.	NULL
M.	NULL
Weaver	NULL
,	NULL
J.	NULL
P.	NULL
Hoeffler	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Wilson	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
proximal	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
interferon-y	NULL
promoter	NULL
mediates	NULL
selective	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:31964	NULL
.	NULL

Barbulescu	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Becker	NULL
,	NULL
J.	NULL
F.	NULL
Schlaak	NULL
,	NULL
E.	NULL
Schmit	NULL
,	NULL
K.	NULL
H.	NULL
Meyer	NULL
zum	NULL
Buschenfelde	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Neurath	NULL
.	NULL

1998	NULL
.	NULL

IL-12	NULL
and	NULL
IL-18	NULL
differentially	NULL
regulate	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
IFN-y	NULL
promoter	NULL
in	NULL
primary	NULL
CD4	NULL
*	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:3642	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Zhang	NULL
,	NULL
H.	NULL
Avraham	NULL
,	NULL
and	NULL
Y.	NULL
Miyazaki	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
interleukin-3	NULL
expression	NULL
in	NULL
megakaryocytes	NULL
.	NULL

Blood	NULL
88:66	NULL
.	NULL

Wargnier	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Lafauric	NULL
,	NULL
S.	NULL
Legros-Maida	NULL
,	NULL
J.	NULL
F.	NULL
Bourge	NULL
,	NULL
F.	NULL
Sigaux	NULL
,	NULL
M.	NULL
Sasportes	NULL
,	NULL
and	NULL
P.	NULL
Paul	NULL
.	NULL

1998	NULL
.	NULL

Down-regulation	NULL
of	NULL
human	NULL
granzyme	NULL
B	NULL
expression	NULL
by	NULL
glucocorticoids	NULL
:	NULL
dexamethasone	NULL
inhibits	NULL
binding	NULL
to	NULL
the	NULL
Ikaros	NULL
and	NULL
AP-1	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
granzyme	NULL
B	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:35326	NULL
.	NULL

Tacobelli	NULL
,	NULL
M.	NULL
,	NULL
W.	NULL
Wachsman	NULL
,	NULL
and	NULL
K.	NULL
L.	NULL
McGuire	NULL
.	NULL

2000	NULL
.	NULL

Repression	NULL
of	NULL
IL-2	NULL
promoter	NULL
activity	NULL
by	NULL
the	NULL
novel	NULL
basic	NULL
leucine	NULL
zipper	NULL
p21SNFT	NULL
protein	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

165:860	NULL
.	NULL

Yea	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
K.	NULL
H.	NULL
Yang	NULL
,	NULL
and	NULL
N.	NULL
E.	NULL
Kaminski	NULL
.	NULL

2000	NULL
.	NULL

Role	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
and	NULL
activator	NULL
protein-1	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
interleukin-2	NULL
gene	NULL
transcription	NULL
by	NULL
cannabinol	NULL
in	NULL
EL4	NULL
T-cells	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

Exp	NULL
.	NULL

Ther	NULL
.	NULL

292:597	NULL
.	NULL

Mori	NULL
,	NULL
A.	NULL
,	NULL
0	NULL
.	NULL

Kaminuma	NULL
,	NULL
T.	NULL
Mikami	NULL
,	NULL
S.	NULL
Inoue	NULL
,	NULL
Y.	NULL
Okumura	NULL
,	NULL
K.	NULL
Akiyama	NULL
,	NULL
and	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

H.	NULL
Okudaira	NULL
.	NULL

1999	NULL
.	NULL

Transcriptional	NULL
control	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
by	NULL
human	NULL
helper	NULL
T	NULL
cells	NULL
:	NULL
IL-5	NULL
synthesis	NULL
is	NULL
regulated	NULL
independently	NULL
from	NULL
IL-2	NULL
or	NULL
IL-4	NULL
synthesis	NULL
.	NULL

J	NULL
.	NULL

Allergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

103:85429	NULL
.	NULL

Santana	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
G.	NULL
Pedraza-Alva	NULL
,	NULL
N.	NULL
Olivares-Zavaleta	NULL
,	NULL
V.	NULL
Madrid-Marina	NULL
,	NULL
V.	NULL
Horejsi	NULL
,	NULL
S.	NULL
J.	NULL
Burakoff	NULL
,	NULL
and	NULL
Y.	NULL
Rosenstein	NULL
.	NULL

2000	NULL
.	NULL

CD43-mediated	NULL
signals	NULL
induce	NULL
DNA-binding	NULL
activity	NULL
of	NULL
AP-1	NULL
,	NULL
NF-AT	NULL
and	NULL
NFKB	NULL
transcription	NULL
factors	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275:31460	NULL
.	NULL

Dong	NULL
,	NULL
C.	NULL
,	NULL
D.	NULL
D.	NULL
Yang	NULL
,	NULL
C.	NULL
Tournier	NULL
,	NULL
A.	NULL
J.	NULL
Whitmarsh	NULL
,	NULL
J.	NULL
Xu	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

2000	NULL
.	NULL

JNK	NULL
is	NULL
required	NULL
for	NULL
effector	NULL
T-cell	NULL
function	NULL
but	NULL
not	NULL
for	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
405:91	NULL
.	NULL

Billadeau	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
S.	NULL
M.	NULL
Mackie	NULL
,	NULL
R.	NULL
A.	NULL
Schoon	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Leibson	NULL
.	NULL

2000	NULL
.	NULL

Specific	NULL
subdomains	NULL
of	NULL
Vay	NULL
differentially	NULL
affect	NULL
T	NULL
cell	NULL
and	NULL
NK	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

164:3971	NULL
.	NULL

Matthews	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
O'Neill	NULL
.	NULL

1999	NULL
.	NULL

Distinct	NULL
roles	NULL
for	NULL
p42/p44	NULL
and	NULL
p38	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
by	NULL
IL-1	NULL
.	NULL

Cytokine	NULL
11:643	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

6195	NULL
Mortellaro	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Songia	NULL
,	NULL
P.	NULL
Gnocchi	NULL
,	NULL
M.	NULL
Ferrari	NULL
,	NULL
C.	NULL
Fornasiero	NULL
,	NULL
R.	NULL
D'Alessio	NULL
,	NULL
A.	NULL
Isetta	NULL
,	NULL
F.	NULL
Colotta	NULL
,	NULL
and	NULL
J.	NULL
Golay	NULL
.	NULL

1999	NULL
.	NULL

New	NULL
immunosuppressive	NULL
drug	NULL
PNU156804	NULL
blocks	NULL
IL-2-dependent	NULL
proliferation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:7102	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
T.	NULL
Kadlecek	NULL
,	NULL
W.	NULL
Zhang	NULL
,	NULL
L.	NULL
E.	NULL
Samelson	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1998	NULL
.	NULL

LAT	NULL
is	NULL
required	NULL
for	NULL
TCR-mediated	NULL
activation	NULL
of	NULL
PLCy1	NULL
and	NULL
the	NULL
Ras	NULL
pathway	NULL
.	NULL

Immunity	NULL
9:617	NULL
.	NULL

Torgerson	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
A.	NULL
D.	NULL
Colosia	NULL
,	NULL
J.	NULL
P.	NULL
Donahue	NULL
,	NULL
Y	NULL
.	NULL

Z.	NULL
Lin	NULL
,	NULL
and	NULL
J.	NULL
Hawiger	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AP-1	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
STAT	NULL
1	NULL
nuclear	NULL
import	NULL
in	NULL
T	NULL
lymphocytes	NULL
by	NULL
noninvasive	NULL
delivery	NULL
of	NULL
peptide	NULL
carrying	NULL
the	NULL
nuclear	NULL
localization	NULL
sequence	NULL
of	NULL
NF-B	NULL
p50	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:6084	NULL
.	NULL

Matsui	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Omura	NULL
,	NULL
H.	NULL
Cui	NULL
,	NULL
S.	NULL
L.	NULL
Schauer	NULL
,	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Ju	NULL
.	NULL

1997	NULL
.	NULL

Proteasome	NULL
regulation	NULL
of	NULL
Fas	NULL
ligand	NULL
cytotoxicity	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27	NULL
;	NULL
2269	NULL
.	NULL

Valle	NULL
Blazquez	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Luque	NULL
,	NULL
E.	NULL
Collantes	NULL
,	NULL
E.	NULL
Aranda	NULL
,	NULL
R.	NULL
Solana	NULL
,	NULL
J.	NULL
Pena	NULL
,	NULL
and	NULL
E.	NULL
Munoz	NULL
.	NULL

1997	NULL
.	NULL

Cellular	NULL
redox	NULL
status	NULL
influences	NULL
both	NULL
cytotoxic	NULL
and	NULL
NF-KB	NULL
activation	NULL
in	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Immunology	NULL
90:455	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

